Herbicide / safener combinations based on safeners from the class of substituted [(1,5-diphenyl-1h-1,2,4-triazol-3-yl)oxy] acetic acids and herbicides from the class of substituted cyclic diones and the salts thereof

Abstract

The present invention relates to combinations comprising one or more components (A) active as safener and one or more herbicidally active compounds (component (B)), wherein component (A) represents one or more compounds of general formula (I) or agrochemically compatible salts thereof, (I) and component (B) represents one or more herbicides. The application further relates to a process and to the use of the herbicide / safener combinations of the invention for weed control or for growth regulation.

Description

[0001] Herbicide / safener combinations based on safeners from the class of substituted [(1,5-diphenyl-1H-1,2,4-triazol-3-yl)oxy]acetic acids and herbicides from the class of substituted cyclic diones and salts thereof Description The invention lies in the technical field of crop protection agents which can be used against undesired plant growth in cultivated land, for seed preparation or in plant crops and which contain a combination of at least one safener (A) and at least one herbicide (B), where the safener (A) corresponds to one or more substituted [(1,5-diphenyl-1H-1,2,4-triazol-3-yl)oxy]acetic acids of the general formula (I) and / or their agrochemically acceptable salts (hereinafter also component (A)).The effectiveness of known herbicides against weeds is at a high level, but generally depends on the application rate, the respective preparation form, the weed spectrum, the weeds to be controlled, the climatic and soil conditions, etc., but above all on crop compatibility. One possibility for improving the application profile of a herbicide can be to combine a safener with one or more herbicidal active ingredients that contribute the desired additional properties. However, phenomena of physical and biological incompatibility often occur when several active ingredients are used in combination, e.g. insufficient stability in a co-formulation, decomposition of an active ingredient orAntagonism of the active ingredients, or the safeners have a limited range of action, protecting the crop only against one herbicide but not against all components in the case of combined applications of several herbicides. Safeners, also called antidotes, with different chemical structures have been known for around 70 years. It is also known that they differ significantly in their protective functions, i.e., their use is limited to selected herbicides and / or the crops to be protected. In addition, it is required that a selected herbicide / safener combination does not negatively affect the herbicidal efficacy with respect to the weeds to be controlled. [(1,5-Diphenyl-1H-1,2,4-triazol-3-yl)oxy]acetic acid derivatives and their salts are known from the PCT application with the application number PCT / EP2020 / 083167 (WO2021 / 105101).Substituted cyclic diones and their salts are known, for example, from PCT application number WO2015 / 197468. It has now been found that compounds from the class of substituted [(1,5-diphenyl-1H-1,2,4-triazol-3-yl)oxy]acetic acids can be used extremely effectively to protect various crops when applying one or more herbicides from the class of substituted cyclic diones (hereinafter referred to as component B). The herbicide / safener combinations according to the invention interact in a particularly advantageous manner, e.g., when used to combat unwanted plant growth in crops such as wheat (durum and soft wheat), maize, soybeans, sugar beet, sugar cane, cotton, rice, beans (such as, for example, bush beans and horse beans), flax, barley, oats, rye, triticale, potatoes, and sorghum.The present invention thus relates to combinations comprising one or more component(s) (A) acting as safeners and one or more herbicidally active compound(s) as component (B), where (A) represents one or more compounds of the general formula (I) or their agrochemically acceptable salts. stands, R c stands for hydrogen, and R dfür Wasserstoff, Methyl, Ethyl, n-Propyl, i-Propyl, n-Butyl, n-Pentyl, Phenyl, Benzyl, CH2(4-Cl-Ph), CH2(4-F-Ph), CH2(4-OMe-Ph), 2-Methoxyethyl, Tetrahydrofuran-2-yl- methyl, Tetrahydrofuran-3-yl-methyl, Tetrahydropyran-2-yl-methyl, Tetrahydropyran-3-yl- methyl, Tetrahydropyran-4-yl-methyl, Methylpropionat-3-yl, Ethylpropionat-3-yl, Methylacetat-2-yl, Ethylacetat-2-yl, Methylpivalat-2-yl, Ethylpivalat-3-yl, Methyl-2- methylpropanoat-3-yl, Methyl-2,2-dimethylpropanoat-3-yl, Ethyl-2-methylpropanoat-3-yl, Methyl-2-propanoat-2-yl, Ethyl-2-propanoat-2-yl, Methyl-acetat-2yl, Ethyl-acetat-2yl, Methyl-1-methylcyclopropancarboxylat-2yl, Ethyl-1-methylcyclopropan-carboxylat-2yl, 2-(Dimethylamino)ethyl, Oxetan-3-yl, (3-Methyloxetan-3-yl)methyl, 2,2,2-Trifluorethyl, 2,2-Difluorethyl, 2-Fluorethyl, 2,2,3,3,3-Pentafluorpropyl, Cyclopropylmethyl, 1- Cyclopropyl-ethyl, (1-Methyl-cyclopropyl)-methyl, (2,2-Dichlorcyclopropyl)-methyl, (2,2- Dimethyl-cyclopropyl)-methyl, Allyl, Propargyl (Prop-2-in-1-yl),2-Chloroprop-2-en-1-yl, 3-Phenylprop-2-yn-1-yl, 3,3-Dichloroprop-2-en-1-yl, 3,3-Dichloro-2-fluoro-prop-2-en-1-yl, Methylprop-2-yn-1-yl, 2-Methylprop-2-en-1-yl, But-2-en-1-yl, But-3-en-1-yl, But-2-yn-1-yl, but-3-yn-1-yl, 4-chloro-but-2-yn-1-yl, 3-methyl-but-2-en-1-yl, 3-methyl-but-1-en-1-yl, 1-(2E)-1-methylbut-2-en-1-yl, (E)-pent-3-en-2-yl or (Z)-Pent-3-en-2-yl, cyclobutylmethyl, Cyclopentylmethyl, cyclohexylmethyl, heptan-2-yl, isobutyl, 1,3-dioxolan-2-ylmethyl or 1-ethyl-5-methyl-1-pyrazol-4-methyl, and (B) represents one or more herbicides from the group of herbicidally active ingredients with the general formula (II) or their agrochemically acceptable salts,

[0002] where R 1 represents (C1-C3)-alkoxy, (C1-C2)-alkoxy-(C1-C3)-alkoxy, (C1-C2)-fluoroalkoxy, ethyl, n-propyl, n-butyl, cyclopropyl or ethynyl, R 2represents hydrogen, ethyl, n-propyl, cyclopropyl, vinyl, ethynyl, (C1-C3)-alkoxy, (C1-C3)-fluoroalkyl, (C1-C2)-fluoroalkoxy, (C1-C2)-alkoxy-(C1-C3)-alkoxy- or C1-fluoroalkoxy-(C1-C3)-alkoxy-; provided that R 2 represents hydrogen, ethyl, n-propyl, cyclopropyl, vinyl or ethynyl, if R 1 represents ethyl, n-propyl, n-butyl, cyclopropyl or ethynyl, R 3 , R 4 , R 5 and R 6independently of one another represent hydrogen, (C1-C5)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, (C1-C2)-fluoroalkyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, (C1-C3)-alkylthio-(C1-C3)-alkyl, (C1-C3)-alkylsulfinyl-(C1-C3)-alkyl, (C1-C3)-alkylsulfonyl-(C1-C3)-alkyl, (C3-C4)-cycloalkyl or represent an unsubstituted 4, 5 or 6-membered monocyclic heterocyclyl ring which carries a ring heteroatom selected from the group consisting of oxygen, sulfur or nitrogen and which is attached to a ring carbon atom within the heterocyclyl group (preferably tetrahydrofuranyl such as Tetrahydrofuran-3-yl, or tetrahydropyranyl such as tetrahydropyran-4-yl), provided that not more than one of the radicals from the group R 3 , R 4 , R 5 and R 6 represents alkenyl, alkynyl, alkoxyalkyl, alkylthioalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl, cycloalkyl or heterocyclyl, or R 3 and R 4 together a group -(CH2)n1 - or -(CH2) n2 -X 1 -(CH2) n3 - form and R 5 and R 6 as defined above, or R 5 and R 6 together a group -(CH2) n1 - or -(CH2) n2 -X 1 -(CH2) n3 - form and R 3 and R 4 as defined above, where X 1 represents O (oxygen), S (sulfur), S(=O), S(=O)2, NH, N((C1-C2)-alkyl), N((C1-C2)-alkoxy), C(H)((C1-C2)-alkyl), C((C1-C2)-alkyl)2 or C(H)((C1-C2)-alkoxy); n1 represents 2, 3, 4 or 5, n2 and n3 independently represent 1, 2 or 3, provided that n2 + n3 is equal to 2, 3 or 4, or R 4 and R 5 together a group –(CH2) n4 - or –(CH2) n5 -C(R 7a )(R 7b )-(CH2) n6 - or - C(R 7c )=C(R 7d )-, where R 7a represents (C1-C2)-alkyl or (C1-C2)-alkoxy; and R 7brepresents hydrogen or (C1-C2)-alkyl, provided that R 7b represents hydrogen if R 7a represents (C1-C2)-alkoxy and wherein n4 represents 1, 2 or 3 and n5 and n6 independently represent 0, 1 or 2, with the proviso that n5 + n6 is equal to 0, 1 or 2 and wherein R 7c and R 7d independently of one another represent hydrogen or (C1-C2)-alkyl, Y represents O (oxygen), S (sulfur), S(=O), S(=O)2, N((C1-C2)-alkyl), N((C1-C2)-alkoxy), C(=O), a group CR 8 R 9 or -CR 10 R 11 CR 12 R 13 - stands, R 8 and R 9independently of one another represent hydrogen, (C1-C6)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, (C1-C2)-fluoroalkyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, (C1-C3)-alkylthio-(C1-C3)-alkyl, (C1-C3)-alkylsulfinyl-(C1-C3)-alkyl, (C1-C3)-alkylsulfonyl-(C1-C3)-alkyl, (C3-C6)-cycloalkyl or substituted (C3-C6)-cycloalkyl which is independently substituted by one or two (C1-C3)-alkyl or (C1-C2)-fluoroalkyl groups or (C4-C6)-cycloalkyl in which one CH2 group is optionally substituted by O (oxygen), S (sulfur), S(=O), S(=O)2, NH, N((C1-C3)-alkyl), N((C1-C2)-alkoxy), N((C1-C2)-fluoroalkyl), N[C(=O)-(C1-C3)-alkyl], N[C(=O)-(C1-C2)-fluoroalkyl] or represents (C3-C6)-cycloalkyl which is substituted by a (C1-C3)-alkoxy group and optionally additionally substituted by a (C1-C2)-alkyl group; or represents (C5-C6)-cycloalkenyl or (C5-C6)-cycloalkenyl,which bears one or two (C1-C3)-alkyl substituents or is (C3-C6)-cycloalkyl-(C1-C2)-alkyl or is substituted (C3-C6)-cycloalkyl-(C1-C2)-alkyl which is independently substituted by one or two (C1-C3)-alkyl or (C1-C2)-fluoroalkyl groups or is (C4-C6)-cycloalkyl-(C1-C2)-alkyl, in which one CH2- group in the ring is optionally substituted by O (oxygen), S (sulfur), S(=O), S(=O)2, NH, N((C1-C2)-alkyl), N((C1-C2)-alkoxy), N((C1-C2)-fluoroalkyl), N[C(=O)-(C1-C3)-alkyl], N[C(=O)-(C1- C2)-fluoroalkyl] or represents (C3-C6)-cycloalkyl-(C1-C2)-alkyl which is substituted on the ring by a (C1-C3)-alkoxy group and optionally additionally substituted on the ring by a (C1-C2)-alkyl group or represents heteroaryl, heteroaryl-CH2-, where the heteroaryl ring is attached via a ring carbon atom and is optionally further substituted by 1, 2 or 3 substituents attached to ring carbon atoms from the group consisting of halogen, cyano, nitro, hydroxy,(C1-C3)-alkyl, (C1-C3)-alkyl-C(=O)-, (C1-C2)-fluoroalkyl-C(=O)-, (C1-C3)-alkoxy, (C1-C2)-fluoroalkoxy, (C2-C3)-alkenyl, (C2-C3)-alkynyl, (C1-C2)-fluoroalkyl with the proviso that a ring carbon atom is not substituted by a halogen (other than fluorine), alkoxy or fluoroalkoxy if this ring carbon atom is directly bonded to a ring nitrogen atom of the heteroaryl ring; and in the case of a 5-membered heteroaryl group which carries at least one nitrogen atom in the ring and which is not part of a C=N double bond, this nitrogen atom is optionally substituted by a substituent from the group (C1-C3)-alkyl, (C1-C2)-fluoroalkyl, (C1-C3)-alkyl-C(=O)-, (C1-C2)-fluoroalkyl-C(=O)-, (C1-C2)-alkyl-S(=O)2-, with the proviso that a maximum of one of the two substituents R, 8 and R 9an optionally substituted cycloalkyl; an optionally substituted cycloalkyl in which one ring (CH2) unit is replaced by O (oxygen), S (sulfur), S(=O), S(=O)2, NH, N((C1-C3)alkyl), N((C1-C2)fluoroalkyl), N[C(=O)-(C1-C3)alkyl], N[C(=O)-(C1-C2)fluoroalkyl] or N((C1-C2)alkoxy); an optionally substituted cycloalkenyl; an optionally substituted cycloalkylalkyl; an optionally substituted cycloalkylalkyl in which one ring (CH2) unit is replaced by O (oxygen), S (sulfur), S(=O), S(=O)2, NH, N((C1-C3)-alkyl), N((C1-C2)-fluoroalkyl), N[C(=O)-(C1-C3)-alkyl], N[C(=O)-(C1-C2)-fluoroalkyl] or N((C1-C2)-alkoxy); or heteroaryl or heteroaryl-CH2-; or R 8 represents hydrogen or (C1-C2)-alkyl when R 9 represents (C1-C2)-alkoxy, or R 8 and R 9 together for -(CH2)n7- or -(CH2)n8-X 2 -(CH2)n9-, where X 2represents S (sulfur), S(=O), S(=O)2, C(H)[(C1-C3)-alkyl], C[(C1-C2)-alkyl]2, C(H)[(C1-C3)-alkoxy] and n7 represents 2, 3, 4, 5, and 6 and n8 and n9 independently represent 0, 1, 2, 3, with the proviso that n8 + n9 is equal to 2, 3, 4, 5, R 10 , R 11 , R 12 and R 13 independently represent hydrogen, (C1-C4)-alkyl, with the proviso that no more than one group R 10 , R 11 , R 12 and R 13 represents (C3-C4)-alkyl, G represents hydrogen, an agronomically acceptable metal, an agronomically acceptable sulfonium group, an agronomically acceptable ammonium group, a group C(X 3 )-R 14 , -C(X 4 )-X 5 -R 15 , -C(X 6 )- N(R 16 )-R 17 , -SO2-R 18 , -P(X 7 )(R 19 )-R 20 , -CH2-X 8 -R 21, (C1-C6)-alkoxy-C(=O)-CH2-, (C1-C6)-alkoxy-C(=O)-CH=CH-, (C2-C7)-alken-1-yl-CH2-, (C2-C7)-alken-1-yl-CH[(C1-C2)-alkyl]-, (C2- C4)-fluoroalken-1-yl-CH2-, (C2-C7)-alkyn-1-yl-CH2-, (C2-C7)-alkyn-1-yl-CH[(C1-C2)-alkyl]-, heteroaryl-CH2-, heteroaryl-CH[(C1-C2)-alkyl]-, phenyl-CH2-, Phenyl-CH[(C1-C2)-alkyl]-, phenyl-C(O)-CH2- is where the phenyl or heteroaryl group optionally continues is independently substituted by 1, 2 or 3 groups selected from (C1-C2)-alkyl, C1-fluoroalkyl, (C1-C2)-alkoxy, C1-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, X 3 , X 4 , X 5 , X 6 , X 7 and X 8 independently represent O (oxygen) and S (sulfur), R 14 for hydrogen, (C1-C 21 )-alkyl, (C2-C 21 )-alkenyl, (C2-C 18 )-alkynyl, (C1-C 10 )-fluoroalkyl, (C1- C 10 )-cyanoalkyl, (C1-C 10 )-nitroalkyl, (C1-C 10)-Aminoalkyl, (C1-C5)-Alkylamino(C1-C5)-alkyl, (C2-C8)-Dialkylamino(C1-C5)-alkyl, (C3-C7)-Cycloalkyl-(C1-C5)-alkyl, (C1-C5)-Alkoxy-(C1-C5)- alkyl, (C3-C5)-Alkenyloxy-(C1-C5)-alkyl, (C3-C5)-Alkinyloxy-(C1-C5)-alkyl, (C1-C5)-Alkylthio- (C1-C5)-alkyl, (C1-C5)-Alkylsulfinyl-(C1-C5)-alkyl, (C1-C5)-Alkylsulfonyl-(C1-C5)-alkyl, (C2-C8)- Alkylidenaminoxy(C1-C5)-alkyl, (C1-C5)-Alkylcarbonyl-(C1-C5)-alkyl, (C1-C5)- Alkoxycarbonyl(C1-C5)-alkyl, Aminocarbonyl-(C1-C5)-alkyl, (C1-C5)-Alkylaminocarbonyl-(C1- C5)-alkyl, (C2-C8)-Dialkylaminocarbonyl-(C1-C5)-alkyl, (C1-C5)-Alkylcarbonylamino-(C1-C5)- alkyl, N-(C1-C5)-Alkylcarbonyl-N-(C1-C5)-alkylamino(C1-C5)-alkyl, (C3-C6)-Trialkylsilyl-(C1- C5)-alkyl, Phenyl-(C1-C5)-alkyl, wobei die Phenylgruppe gegebenenfalls weiter unabhänig voneinander durch 1, 2 oder 3 Gruppen ausgewählt aus (C1-C3)-Alkyl, (C1-C3)-FluoralkyI, (C1- C2)-Alkoxy, (C1-C3)-Fluoralkoxy, (C1-C3)-Alkylthio, (C1-C3)-Alkylsulfinyl, (C1-C3)- Alkylsulfonyl, Fluor, Chlor, Brom, Cyano,Nitro is substituted, heteroaryl-(C1-C5)-alkyl, wherein the heteroaryl group is optionally further substituted independently of one another by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, fluorine, chlorine, bromine, cyano, nitro, (C2-C5)-fluoroalkenyl, (C3-C8)-cycloalkyl; Phenyl or phenyl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroaryl or which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, R, 15 for (C1-C 18 )-alkyl, (C3-C 18 )-alkenyl, (C3-C 18 )-alkynyl, (C2-C 10 )-fluoroalkyl, (C1-C 10 )-cyanoalkyl, (C1-C10 )-Nitroalkyl, (C2-C 10)-Aminoalkyl, (C1-C5)-Alkylamino(C1-C5)-alkyl, (C2-C8)- Dialkylamino(C1-C5)-alkyl, (C3-C7)-Cycloalkyl-(C1-C5)-alkyl, (C1-C5)-Alkoxy-(C1-C5)-alkyl, (C3- C5)-Alkenyloxy-(C1-C5)-alkyl, (C3-C5)-Alkinyloxy-(C1-C5)-alkyl, (C1-C5)-Alkylthio-(C1-C5)- alkyl, (C1-C5)-Alkylsulfinyl-(C1-C5)-alkyl, (C1-C5)-Alkylsulfonyl-(C1-C5)-alkyl, (C2-C8)- Alkylidenaminoxy(C1-C5)-alkyl, (C1-C5)-Alkylcarbonyl-(C1-C5)-alkyl, (C1-C5)- Alkoxycarbonyl(C1-C5)-alkyl, Aminocarbonyl-(C1-C5)-alkyl, (C1-C5)-Alkylaminocarbonyl-(C1- C5)-alkyl, (C2-C8)-Dialkylaminocarbonyl-(C1-C5)-alkyl, (C1-C5)-Alkylcarbonylamino-(C1-C5)- alkyl, N-(C1-C5)-Alkylcarbonyl-N-(C1-C5)-alkylamino(C1-C5)-alkyl, (C3-C6)-Trialkylsilyl-(C1- C5)-alkyl, Phenyl-(C1-C5)-alkyl, wobei die Phenylgruppe gegebenenfalls weiter unabhänig voneinander durch 1, 2 oder 3 Gruppen ausgewählt aus (C1-C3)-Alkyl, (C1-C3)-FluoralkyI, (C1- C2)-Alkoxy, (C1-C3)-Fluoralkoxy, (C1-C3)-Alkylthio, (C1-C3)-Alkylsulfinyl, (C1-C3)- Alkylsulfonyl, Fluor, Chlor, Brom, Cyano,Nitro is substituted, heteroaryl-(C1-C5)-alkyl, wherein the heteroaryl group is optionally further substituted independently of one another by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, fluorine, chlorine, bromine, cyano, nitro, (C2-C5)-fluoroalkenyl, (C3-C8)-cycloalkyl; Phenyl or phenyl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroaryl or heteroaryl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, R, 16 and R 17 independently of each other for hydrogen, (C1-C 10 )-alkyl, (C2-C 10 )-alkenyl, (C2-C 10 )- alkynyl, (C2-C10 )-Fluoralkyl, (C1-C 10 )-Cyanoalkyl, (C1-C 10 )-Nitroalkyl, (C1-C 10)-Aminoalkyl, (C1- C5)-Alkylamino(C1-C5)-alkyl, (C2-C8)-Dialkylamino(C1-C5)-alkyl, (C3-C7)-Cycloalkyl-(C1-C5)- alkyl, (C1-C5)-Alkoxy-(C1-C5)-alkyl, (C3-C5)-Alkenyloxy-(C1-C5)-alkyl, (C3-C5)-Alkinyloxy-(C1- C5)-alkyl, (C1-C5)-Alkylthio-(C1-C5)-alkyl, (C1-C5)-Alkylsulfinyl-(C1-C5)-alkyl, (C1-C5)- Alkylsulfonyl-(C1-C5)-alkyl, (C2-C8)-Alkylidenaminoxy(C1-C5)-alkyl, (C1-C5)-Alkylcarbonyl-(C1- C5)-alkyl, (C1-C5)-Alkoxycarbonyl(C1-C5)-alkyl, Aminocarbonyl-(C1-C5)-alkyl, (C1-C5)- Alkylaminocarbonyl-(C1-C5)-alkyl, (C2-C8)-Dialkylaminocarbonyl-(C1-C5)-alkyl, (C1-C5)- Alkylcarbonylamino-(C1-C5)-alkyl, N-(C1-C5)-Alkylcarbonyl-N-(C1-C5)-alkylamino(C1-C5)-alkyl, (C3-C6)-Trialkylsilyl-(C1-C5)-alkyl, Phenyl-(C1-C5)-alkyl, wobei die Phenylgruppe gegebenenfalls weiter unabhänig voneinander durch 1, 2 oder 3 Gruppen ausgewählt aus (C1-C3)-Alkyl, (C1-C3)- FluoralkyI, (C1-C2)-Alkoxy, (C1-C3)-Fluoralkoxy, (C1-C3)-Alkylthio, (C1-C3)-Alkylsulfinyl, (C1- C3)-Alkylsulfonyl, Fluor, Chlor, Brom, Cyano,Nitro is substituted, heteroaryl-(C1-C5)-alkyl, wherein the heteroaryl group is optionally further substituted independently of one another by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, fluorine, chlorine, bromine, cyano, nitro, (C2-C5)-fluoroalkenyl, (C3-C8)-cycloalkyl; Phenyl or phenyl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroaryl or heteroaryl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroarylamino or heteroarylamino in which the heteroaryl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl,(C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, diheteroarylamino or diheteroarylamino in which the respective heteroaryl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, phenylamino or phenylamino in which the respective phenyl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, Diphenylamino or diphenylamino, in which the respective phenyl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, (C3-C7)-cycloalkylamino, di-[(C3-C7)-cycloalkyl]amino, (C3-C7)-cycloalkoxy; or R, 16 and R 17, together with the nitrogen atom to which they are attached, form an unsubstituted 4- to 7-membered ring, optionally comprising a heteroatom selected from the group consisting of O (oxygen) and S (sulfur), R 18 for (C1-C 10 )-alkyl, (C2-C 10 )-alkenyl, (C2-C 10 )-alkynyl, (C1-C 10 )-fluoroalkyl, (C1-C 10 )-cyanoalkyl, (C1-C 10 )-nitroalkyl, (C1-C 10)-Aminoalkyl, (C1-C5)-Alkylamino(C1-C5)-alkyl, (C2-C8)- Dialkylamino(C1-C5)-alkyl, (C3-C7)-Cycloalkyl-(C1-C5)-alkyl, (C1-C5)-Alkoxy-(C1-C5)-alkyl, (C3- C5)-Alkenyloxy-(C1-C5)-alkyl, (C3-C5)-Alkinyloxy-(C1-C5)-alkyl, (C1-C5)-Alkylthio-(C1-C5)- alkyl, (C1-C5)-Alkylsulfinyl-(C1-C5)-alkyl, (C1-C5)-Alkylsulfonyl-(C1-C5)-alkyl, (C2-C8)- Alkylidenaminoxy(C1-C5)-alkyl, (C1-C5)-Alkylcarbonyl-(C1-C5)-alkyl, (C1-C5)- Alkoxycarbonyl(C1-C5)-alkyl, Aminocarbonyl-(C1-C5)-alkyl, (C1-C5)-Alkylaminocarbonyl-(C1- C5)-alkyl, (C2-C8)-Dialkylaminocarbonyl-(C1-C5)-alkyl, (C1-C5)-Alkylcarbonylamino-(C1-C5)- alkyl, N-(C1-C5)-Alkylcarbonyl-N-(C1-C5)-alkylamino(C1-C5)-alkyl, (C3-C6)-Trialkylsilyl-(C1- C5)-alkyl, Phenyl-(C1-C5)-alkyl, wobei die Phenylgruppe gegebenenfalls weiter unabhänig voneinander durch 1, 2 oder 3 Gruppen ausgewählt aus (C1-C3)-Alkyl, (C1-C3)-FluoralkyI, (C1- C2)-Alkoxy, (C1-C3)-Fluoralkoxy, (C1-C3)-Alkylthio, (C1-C3)-Alkylsulfinyl, (C1-C3)- Alkylsulfonyl, Fluor, Chlor, Brom, Cyano,Nitro is substituted, heteroaryl-(C1-C5)-alkyl, wherein the heteroaryl group is optionally further substituted independently of one another by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, fluorine, chlorine, bromine, cyano, nitro, (C2-C5)-fluoroalkenyl, (C3-C8)-cycloalkyl; Phenyl or phenyl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroaryl or heteroaryl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroarylamino or heteroarylamino in which the heteroaryl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl,(C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, diheteroarylamino or diheteroarylamino in which the respective heteroaryl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, phenylamino or phenylamino in which the respective phenyl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, diphenylamino or diphenylamino, in which the respective phenyl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, (C3-C7)-cycloalkylamino, di-[(C3-C7)-cycloalkyl]amino, (C3-C7)-cycloalkoxy, (C1-C, 10 )-alkoxy, (C1-C 10)-fluoroalkoxy, (C3-C7)-alkylamino, di-[(C3-C7)-alkyl]amino; R 19 and R 20 independently for (C1-C 10 )-alkyl, (C2-C 10 )-alkenyl, (C2-C 10 )-alkynyl, (C1-C 10 )- fluoroalkyl, (C1-C 10 )-cyanoalkyl, (C1-C 10 )-nitroalkyl, (C1-C 10)-Aminoalkyl, (C1-C5)- Alkylamino(C1-C5)-alkyl, (C2-C8)-Dialkylamino(C1-C5)-alkyl, (C3-C7)-Cycloalkyl-(C1-C5)-alkyl, (C1-C5)-Alkoxy-(C1-C5)-alkyl, (C3-C5)-Alkenyloxy-(C1-C5)-alkyl, (C3-C5)-Alkinyloxy-(C1-C5)- alkyl, (C1-C5)-Alkylthio-(C1-C5)-alkyl, (C1-C5)-Alkylsulfinyl-(C1-C5)-alkyl, (C1-C5)- Alkylsulfonyl-(C1-C5)-alkyl, (C2-C8)-Alkylidenaminoxy(C1-C5)-alkyl, (C1-C5)-Alkylcarbonyl-(C1- C5)-alkyl, (C1-C5)-Alkoxycarbonyl(C1-C5)-alkyl, Aminocarbonyl-(C1-C5)-alkyl, (C1-C5)- Alkylaminocarbonyl-(C1-C5)-alkyl, (C2-C8)-Dialkylaminocarbonyl-(C1-C5)-alkyl, (C1-C5)- Alkylcarbonylamino-(C1-C5)-alkyl, N-(C1-C5)-Alkylcarbonyl-N-(C1-C5)-alkylamino(C1-C5)-alkyl, (C3-C6)-Trialkylsilyl-(C1-C5)-alkyl, Phenyl-(C1-C5)-alkyl, wobei die Phenylgruppe gegebenenfalls weiter unabhänig voneinander durch 1, 2 oder 3 Gruppen ausgewählt aus (C1-C3)-Alkyl, (C1-C3)- FluoralkyI, (C1-C2)-Alkoxy, (C1-C3)-Fluoralkoxy, (C1-C3)-Alkylthio, (C1-C3)-Alkylsulfinyl, (C1- C3)-Alkylsulfonyl, Fluor, Chlor, Brom, Cyano,Nitro is substituted, heteroaryl-(C1-C5)-alkyl, wherein the heteroaryl group is optionally further substituted independently of one another by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, fluorine, chlorine, bromine, cyano, nitro, (C2-C5)-fluoroalkenyl, (C3-C8)-cycloalkyl; Phenyl or phenyl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroaryl or heteroaryl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroarylamino or heteroarylamino in which the heteroaryl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl,(C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, diheteroarylamino or diheteroarylamino in which the respective heteroaryl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, phenylamino or phenylamino in which the respective phenyl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, Diphenylamino or diphenylamino, in which the respective phenyl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, benzyloxy and phenyloxy, wherein the respective phenyl group is optionally further substituted independently by 1,2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, and R, 21 for (C1-C 10 )-alkyl, (C3-C 10 )-alkenyl, (C3-C 10 )-alkynyl, (C1-C 10 )-fluoroalkyl, (C1-C 10 )-cyanoalkyl, (C1-C 10 )-nitroalkyl, (C2-C 10)-Aminoalkyl, (C1-C5)-Alkylamino(C1-C5)-alkyl, (C2-C8)- Dialkylamino(C1-C5)-alkyl, (C3-C7)-Cycloalkyl-(C1-C5)-alkyl, (C1-C5)-Alkoxy-(C1-C5)-alkyl, (C3- C5)-Alkenyloxy-(C1-C5)-alkyl, (C3-C5)-Alkinyloxy-(C1-C5)-alkyl, (C1-C5)-Alkylthio-(C1-C5)- alkyl, (C1-C5)-Alkylsulfinyl-(C1-C5)-alkyl, (C1-C5)-Alkylsulfonyl-(C1-C5)-alkyl, (C2-C8)- Alkylidenaminoxy(C1-C5)-alkyl, (C1-C5)-Alkylcarbonyl-(C1-C5)-alkyl, (C1-C5)- Alkoxycarbonyl(C1-C5)-alkyl, Aminocarbonyl-(C1-C5)-alkyl, (C1-C5)-Alkylaminocarbonyl-(C1- C5)-alkyl, (C2-C8)-Dialkylaminocarbonyl-(C1-C5)-alkyl, (C1-C5)-Alkylcarbonylamino-(C1-C5)- alkyl, N-(C1-C5)-Alkylcarbonyl-N-(C1-C5)-alkylamino(C1-C5)-alkyl, (C3-C6)-Trialkylsilyl-(C1- C5)-alkyl, Phenyl-(C1-C5)-alkyl, wobei die Phenylgruppe gegebenenfalls weiter unabhänig voneinander durch 1, 2 oder 3 Gruppen ausgewählt aus (C1-C3)-Alkyl, (C1-C3)-FluoralkyI, (C1- C2)-Alkoxy, (C1-C3)-Fluoralkoxy, (C1-C3)-Alkylthio, (C1-C3)-Alkylsulfinyl, (C1-C3)- Alkylsulfonyl, Fluor, Chlor, Brom, Cyano,Nitro is substituted, heteroaryl-(C1-C5)-alkyl, wherein the heteroaryl group is optionally further substituted independently of one another by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, fluorine, chlorine, bromine, cyano, nitro, phenoxy-(C1-C5)-alkyl, wherein the phenyl group is optionally further substituted independently of one another by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, fluorine, chlorine, bromine, cyano, nitro, heteroaryloxy-(C1-C5)-alkyl, wherein the heteroaryl group is optionally further substituted independently of one another by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, fluorine, chlorine, bromine, cyano, nitro,Phenyl or phenyl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroaryl or heteroaryl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, phenyl-C(=O), where the phenyl group is optionally further independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro. With regard to the compounds according to the invention, the terms used above and below are explained. These are familiar to the person skilled in the art and have, in particular, the meanings explained below: Unless otherwise defined, the following generally applies to the designation of chemical groups:that the connection to the skeleton or the rest of the molecule occurs via the last-mentioned structural element of the chemical group in question, i.e. for example in the case of (C2-C8)-alkenyloxy via the oxygen atom, and in the case of heterocyclyl-(C1-C8)-alkyl or (C1-C6)-alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkyl in each case via the C atom of the alkyl group. In the case of bonds to the rest of the molecule marked with “-”, the bond is not via the last-mentioned structural element, but via the structural motif which is directly next to the bond symbol “-”. Example: In the case of -(CO)(C1-C6)-alkoxy-(C1-C6)-alkyl the bond is via the carbonyl group and not via the (C1-C6)-alkyl group, hence the bond line “-”. According to the invention, “alkylthio” - alone or as part of a chemical group - stands for straight-chain or branched S-alkyl, preferably having 1 to 8, or having 1 to 6 carbon atoms, such as (C1-C, 10)-, (C1-C6)- oder (C1-C4)-Alkylthio, z.B. (aber nicht beschränkt auf) (C1- C6)-Alkylthio wie Methylthio, Ethylthio, Propylthio, 1-Methylethylthio, Butylthio, 1-Methylpropylthio, 2-Methylpropylthio, 1,1-Dimethylethylthio, Pentylthio, 1-Methylbutylthio, 2-Methylbutylthio, 3- Methylbutylthio, 1,1-Dimethylpropylthio, 1,2-Dimethylpropylthio, 2,2-Dimethylpropylthio, 1- Ethylpropylthio, Hexylthio, 1-Methylpentylthio, 2-Methylpentylthio, 3-Methylpentylthio, 4-Methyl- pentylthio, 1,1-Dimethylbutylthio, 1,2-Dimethylbutylthio, 1,3-Dimethylbutylthio, 2,2-Dimethylbutyl- thio, 2,3-Dimethylbutylthio, 3,3-Dimethylbutylthio, 1-Ethylbutylthio, 2-Ethylbutylthio, 1,1,2-Tri- methylpropylthio, 1,2,2-Trimethylpropylthio, 1-Ethyl-1-methylpropylthio und 1-Ethyl-2-methyl- propylthio. „Alkoxy“ bedeutet ein über ein Sauerstoffatom gebundenen Alkylrest, z. B.(but not limited to) (C1-C6)-alkoxy such as methoxy, ethoxy, propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1-dimethylethoxy, pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-Trimethylpropoxy, 1,2,2-Trimethylpropoxy, 1-ethyl-1-methylpropoxy and 1-ethyl-2-methylpropoxy. Alkenyloxy means an alkenyl radical bonded via an oxygen atom, alkynyloxy means an alkynyl radical bonded via an oxygen atom such as (C2-C6). 10 )-, (C2-C6)- or (C2-C4)-alkenoxy or (C3-C 10)-, (C3-C6)- or (C3-C4)-alkynoxy. “Alkylcarbonyl” (alkyl-C(=O)-), unless defined otherwise elsewhere, represents alkyl radicals which are bonded to the skeleton via -C(=O)-, such as (C1-C 10 ), (C1-C6) or (C1-C4) alkylcarbonyl. The number of C atoms refers to the alkyl radical in the alkylcarbonyl group. “Alkoxycarbonyl (alkyl-OC(=O)-)”, unless defined otherwise elsewhere: Alkyl radicals that are bonded to the skeleton via -OC(=O)-, such as (C1-C 10 )-, (C1-C6)- or (C1-C4)-alkoxycarbonyl. The number of C atoms refers to the alkyl radical in the alkoxycarbonyl group. Analogously, "alkenyloxycarbonyl" and "alkynyloxycarbonyl", unless defined otherwise elsewhere, represent alkenyl or alkynyl radicals, respectively, which are bonded to the skeleton via -OC(=O)-, such as (C2-C 10 )-, (C2-C6)- or (C2-C4)-alkenyloxycarbonyl or (C3-C 10), (C3-C6) or (C3-C4) alkynyloxycarbonyl. The number of C atoms refers to the alkenyl or alkynyl radical in the alkene or alkynyloxycarbonyl group. The term "alkylcarbonyloxy" (alkyl-C(=O)-O-) stands for alkyl radicals which are bonded to the skeleton via a carbonyloxy group (-C(=O)-O-), such as (C1-C 10 )-, (C1-C6)- or (C1-C4)-alkylcarbonyloxy. The number of C atoms refers to the alkyl radical in the alkylcarbonyloxy group. In abbreviations such as C(O)R 13 , C(O)OR 13 , OC(O)NR 11 R 12 , or C(O)NR 11 R 12 The abbreviation O in parentheses stands for an oxygen atom bonded to the adjacent carbon atom via a double bond. In abbreviations such as OC(S)OR 13 , OC(S)SR 14 , OC(S)NR 11 R 12, the abbreviation S in parentheses stands for a sulfur atom bonded to the adjacent carbon atom via a double bond. The term “aryl” means an optionally substituted mono-, bi- or polycyclic aromatic system having preferably 6 to 14, in particular 6 to 10 ring C atoms, for example phenyl, naphthyl, anthryl, phenanthrenyl, and the like, preferably phenyl. The term “optionally substituted aryl” also includes multicyclic systems such as tetrahydronaphthyl, indenyl, indanyl, fluorenyl, biphenylyl, where the bonding site is on the aromatic system. From a systematic point of view, “aryl” is generally also included in the term “optionally substituted phenyl”. Preferred aryl substituents here are, for example, hydrogen, halogen, alkyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, halocycloalkyl, alkenyl, alkynyl, aryl, arylalkyl, arylalkenyl, heteroaryl, heteroarylalkyl, heterocyclyl, heterocyclylalkyl, alkoxyalkyl,Alkylthio, Haloalkylthio, Haloalkyl, Alkoxy, Haloalkoxy, Cycloalkoxy, Cycloalkylalkoxy, Aryloxy, Heteroraryloxy, Alkoxyalkoxy, Alkinylalkoxy, Alkenyloxy, Bis-alkylaminoalkoxy, Tris- [alkyl]silyl, Bis-[alkyl]arylsilyl, Bis-[alkyl]alkylsilyl, Tris-[alkyl]silylalkinyl, Arylalkinyl, Heteroarylalkinyl, Alkylalkinyl, Cycloalkylalkinyl, Haloalkylalkinyl, Heterocyclyl-N-alkoxy, Nitro, Cyano, Amino, Alkylamino, Bis-alkylamino, Alkylcarbonylamino, Cycloalkylcarbonylamino, Arylcarbonylamino, Alkoxycarbonylamino, Alkoxycarbonylalkylamino, Arylalkoxycarbonylalkylamino, Hydroxycarbonyl, Alkoxycarbonyl, Aminocarbonyl, Alkylaminocarbonyl, Cycloalkylaminocarbonyl, Bis-Alkylaminocarbonyl, Heteroarylalkoxy, Arylalkoxy. Ein heterocyclischer Rest (Heterocyclyl) enthält mindestens einen heterocyclischen Ring (=carbocyclischer Ring, in dem mindestens ein C-Atom durch ein Heteroatom ersetzt ist, vorzugsweise durch ein Heteroatom aus der Gruppe N, O, S, P) der gesättigt, ungesättigt,is partially saturated or heteroaromatic and may be unsubstituted or substituted, where the bonding site is located on a ring atom. If the heterocyclyl radical or the heterocyclic ring is optionally substituted, it may be fused with other carbocyclic or heterocyclic rings. In the case of optionally substituted heterocyclyl, polycyclic systems are also included, such as, for example, 8-aza-bicyclo[3.2.1]octanyl, 8-aza-bicyclo[2.2.2]octanyl or 1-aza-bicyclo[2.2.1]heptyl. In the case of optionally substituted heterocyclyl, spirocyclic systems are also included, such as, for example, 1-oxa-5-aza-spiro[2.3]hexyl. Unless otherwise defined, the heterocyclic ring preferably contains 3 to 9 ring atoms, in particular 3 to 6 ring atoms, and one or more, preferably 1 to 4, in particular 1, 2 or 3 heteroatoms in the heterocyclic ring, preferably from the group N, O, and S,however, two oxygen atoms should not be directly adjacent, such as, for example, with a heteroatom from the group N, O and S 1- or 2- or 3-pyrrolidinyl, 3,4-dihydro-2H-pyrrol-2- or 3-yl, 2,3-dihydro-1H-pyrrol- 1- or 2- or 3- or 4- or 5-yl; 2,5-dihydro-1H-pyrrol-1- or 2- or 3-yl, 1- or 2- or 3- or 4-piperidinyl; 2,3,4,5-tetrahydropyridin-2- or 3- or 4- or 5-yl or 6-yl; 1,2,3,6-tetrahydropyridin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,2,3,4-Tetrahydropyridin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,4-Dihydropyridin-1- or 2- or 3- or 4-yl; 2,3-Dihydropyridin- 2- or 3- or 4- or 5- or 6-yl; 2,5-Dihydropyridin-2- or 3- or 4- or 5- or 6-yl, 1- or 2- or 3- or 4-azepanyl; 2,3,4,5-Tetrahydro-1H-azepin-1- or 2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-Tetrahydro-1H-azepin-1- or 2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-Tetrahydro-1H-azepin-1- or 2- or 3- or 4-yl; 3,4,5,6-Tetrahydro-2H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5-Dihydro-1H-azepin-1- or 2- or 3- or 4-yl; 2,5-Dihydro-1H-azepin- 1- or -2- or 3- or 4- or 5- or 6- or 7-yl; 2,7-Dihydro-1H-azepin-1- or -2- or 3- or 4- yl; 2,3-Dihydro-1H-azepin-1- or -2- or 3- or 4- or 5- or 6- or 7-yl; 3,4-Dihydro-2H-azepin- 2- or 3- or 4- or 5- or 6- or 7-yl; 3,6-Dihydro-2H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 5,6-Dihydro-2H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5-Dihydro-3H-azepin- 2- or 3- or 4- or 5- or 6- or 7-yl; 1H-azepin-1- or -2- or 3- or 4- or 5- or 6- or 7-yl; 2H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 3H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4H-azepine-2- or 3- or 4- or 5- or 6- or 7-yl, 2- or 3-oxolanyl (= 2- or 3-tetrahydrofuranyl); 2,3-dihydrofuran-2- or 3- or 4- or 5-yl; 2,5-dihydrofuran-2- or 3-yl,2- or 3- or 4-oxanyl (= 2- or 3- or 4-tetrahydropyranyl); 3,4-dihydro-2H-pyran-2- or 3- or 4- or 5- or 6-yl; 3,6-dihydro-2H-pyran-2- or 3- or 4- or 5- or 6-yl; 2H-pyran-2- or 3- or 4- or 5- or 6-yl; 4H-pyran-2- or 3- or 4-yl, 2- or 3- or 4-oxepanyl; 2,3,4,5-tetrahydrooxepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-Tetrahydrooxepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-Tetrahydrooxepin-2- or 3- or 4-yl; 2,3-Dihydrooxepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5-Dihydrooxepin-2- or 3- or 4-yl; 2,5-Dihydrooxepin-2- or 3- or 4- or 5- or 6- or 7-yl; Oxepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2- or 3-Tetrahydrothiophenyl; 2,3-Dihydrothiophene-2- or 3- or 4- or 5-yl; 2,5-Dihydrothiophen-2- or 3-yl; tetrahydro-2H-thiopyran-2- or 3- or 4-yl; 3,4-Dihydro-2H-thiopyran-2- or 3- or 4- or 5- or 6-yl; 3,6-Dihydro-2H-thiopyran-2- or 3- or 4- or 5- or 6-yl; 2H-thiopyran-2- or 3- or 4- or 5- or 6-yl; 4H-thiopyran-2- or 3- or 4-yl. Preferred 3-membered and 4-membered ring heterocycles are, for example, 1- or 2-aziridinyl, oxiranyl, thiiranyl, 1- or 2- or 3-azetidinyl, 2- or 3-oxetanyl, 2- or 3-thietanyl, and 1,3-dioxetan-2-yl. Further examples of “heterocyclyl” are a partially or fully hydrogenated heterocyclic radical having two heteroatoms from the group consisting of N, O, and S, such as, for example, 1- or 2- or 3- or 4-pyrazolidinyl; 4,5-Dihydro-3H-pyrazol- 3- or 4- or 5-yl; 4,5-Dihydro-1H-pyrazol-1- or 3- or 4- or 5-yl; 2,3-Dihydro-1H-pyrazol-1- or 2- or 3- or 4- or 5-yl; 1- or 2- or 3- or 4- imidazolidinyl; 2,3-Dihydro-1H-imidazol-1- or 2- or 3- or 4-yl; 2,5-Dihydro-1H-imidazol-1- or 2- or 4- or 5-yl; 4,5-Dihydro-1H-imidazol-1- or 2- or 4- or 5-yl; Hexahydropyridazin-1- or 2- or 3- or 4-yl; 1,2,3,4-Tetrahydropyridazin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,2,3,6-Tetrahydropyridazin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,4,5,6-Tetrahydropyridazin-1- or 3- or 4- or 5- or 6-yl; 3,4,5,6-Tetrahydropyridazin-3- or 4- or 5-yl; 4,5-Dihydropyridazin-3- or 4-yl; 3,4-Dihydropyridazin-3- or 4- or 5- or 6-yl; 3,6-Dihydropyridazin-3- or 4-yl; 1,6-Dihydropyriazin-1- or 3- or 4- or 5- or 6-yl; Hexahydropyrimidin-1- or 2- or 3- or 4-yl; 1,4,5,6-Tetrahydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 1,2,5,6-Tetrahydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 1,2,3,4-Tetrahydropyrimidin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,6-Dihydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 1,2-Dihydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 2,5-Dihydropyrimidin- 2- or 4- or 5-yl; 4,5-Dihydropyrimidin- 4- or 5- or 6-yl; 1,4-Dihydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 1- or 2- or 3-Piperazinyl; 1,2,3,6-Tetrahydropyrazin-1- or 2- or 3- or 5- or 6-yl; 1,2,3,4-Tetrahydropyrazin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,2-Dihydropyrazin-1- or 2- or 3- or 5- or 6-yl; 1,4-Dihydropyrazin-1- or 2- or 3-yl; 2,3-Dihydropyrazin-2- or 3- or 5- or 6-yl; 2,5-Dihydropyrazin-2- or 3-yl; 1,3-Dioxolan-2- or 4- or 5-yl; 1,3-Dioxol-2- or 4-yl; 1,3-Dioxan-2- or 4- or 5-yl; 4H-1,3-dioxin-2- or 4- or 5- or 6-yl; 1,4-dioxan-2- or 3- or 5- or 6-yl; 2,3-dihydro-1,4-dioxin-2- or 3- or 5- or 6-yl; 1,4-dioxin-2- or 3-yl; 1,2-dithiolan-3- or 4-yl; 3H-1,2-dithiol-3- or 4- or 5-yl; 1,3-dithiolan-2- or 4-yl; 1,3-dithiol- 2- or 4-yl; 1,2-dithian-3- or 4-yl; 3,4-dihydro-1,2-dithiin-3- or 4- or 5- or 6-yl; 3,6-Dihydro- 1,2-dithiin-3- or 4-yl; 1,2-dithiin-3- or 4-yl; 1,3-dithian-2- or 4- or 5-yl; 4H-1,3-dithiin-2- or 4- or 5- or 6-yl; isoxazolidin-2- or 3- or 4- or 5-yl; 2,3-Dihydroisoxazol-2- or 3- or 4- or 5-yl; 2,5-Dihydroisoxazol-2- or 3- or 4- or 5-yl; 4,5-Dihydroisoxazol-3- or 4- or 5-yl; 1,3-Oxazolidin-2- or 3- or 4- or 5-yl; 2,3-Dihydro-1,3-oxazol-2- or 3- or 4- or 5-yl; 2,5-Dihydro-1,3-oxazol-2- or 4- or 5-yl; 4,5-Dihydro-1,3-oxazol-2- or 4- or 5-yl; 1,2-Oxazinan-2- or 3- or 4- or 5- or 6-yl; 3,4-Dihydro-2H-1,2-oxazin-2- or 3- or 4- or 5- or 6-yl; 3,6-Dihydro-2H-1,2-oxazin-2- or 3- or 4- or 5- or 6-yl; 5,6-Dihydro-2H-1,2-oxazin-2- or 3- or 4- or 5- or 6-yl; 5,6-Dihydro-4H-1,2-oxazin-3- or 4- or 5- or 6-yl; 2H-1,2-oxazin-2- or 3- or 4- or 5- or 6-yl; 6H-1,2-oxazin-3- or 4- or 5- or 6-yl; 4H-1,2-oxazin-3- or 4- or 5- or 6-yl; 1,3-Oxazinan-2- or 3- or 4- or 5- or 6-yl; 3,4-Dihydro-2H-1,3-oxazin-2- or 3- or 4- or 5- or 6-yl; 3,6-Dihydro-2H-1,3-oxazin-2- or 3- or 4- or 5- or 6-yl; 5,6-Dihydro-2H-1,3-oxazin-2- or 4- or 5- or 6-yl; 5,6-dihydro-4H-1,3-oxazin-2- or 4- or 5- or 6-yl; 2H-1,3-oxazin-2- or 4- or 5- or 6-yl; 6H-1,3-oxazin-2- or 4- or 5- or 6-yl; 4H-1,3-oxazin-2- or 4- or 5- or 6-yl; morpholin-2- or 3- or 4-yl; 3,4-dihydro-2H-1,4-oxazin-2- or 3- or 4- or 5- or 6-yl; 3,6-dihydro-2H-1,4-oxazin-2- or 3- or 5- or 6-yl; 2H-1,4-oxazin-2- or 3- or 5- or 6-yl; 4H-1,4-oxazin-2- or 3-yl; 1,2-oxazepan-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,5-tetrahydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-tetrahydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-tetrahydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5,6,7-Tetrahydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5,6,7-Tetrahydro-1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl; 2,3-Dihydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5-Dihydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,7-dihydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5-dihydro-1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl; 4,7-dihydro-1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl; 6,7-dihydro-1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl; 1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl; 1,3-Oxazepan-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,5-Tetrahydro-1,3-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-Tetrahydro-1,3-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-Tetrahydro-1,3-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5,6,7-Tetrahydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 4,5,6,7-Tetrahydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 2,3-Dihydro-1,3-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5-Dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 2,7-Dihydro-1,3-oxazepin- 2- or 4- or 5- or 6- or 7-yl; 4,5-dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 4,7-dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 6,7-dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 1,4-oxazepan-2- or 3- or 5- or 6- or 7-yl; 2,3,4,5-Tetrahydro-1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-Tetrahydro-1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-Tetrahydro-1,4-oxazepin- 2- or 3- or 5- or 6- or 7-yl; 2,5,6,7-Tetrahydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; 4,5,6,7-Tetrahydro-1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3-Dihydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; 2,5-Dihydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; 2,7-Dihydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; 4,5-Dihydro-1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,7-Dihydro-1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 6,7-dihydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; 1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; isothiazolidin-2- or 3- or 4- or 5-yl; 2,3-dihydroisothiazol-2- or 3- or 4- or 5-yl; 2,5-dihydroisothiazol-2- or 3- or 4- or 5-yl; 4,5-dihydroisothiazol-3- or 4- or 5-yl; 1,3-thiazolidin-2- or 3- or 4- or 5-yl; 2,3-Dihydro-1,3-thiazol-2- or 3- or 4- or 5-yl; 2,5-Dihydro-1,3-thiazol-2- or 4- or 5-yl; 4,5-Dihydro-1,3-thiazol-2- or 4- or 5-yl; 1,3-Thiazinan-2- or 3- or 4- or 5- or 6-yl; 3,4-Dihydro-2H-1,3-thiazin-2- or 3- or 4- or 5- or 6-yl; 3,6-Dihydro-2H-1,3-thiazin-2- or 3- or 4- or 5- or 6-yl; 5,6-Dihydro-2H-1,3-thiazin-2- or 4- or 5- or 6-yl; 5,6-Dihydro-4H-1,3-thiazin-2- or 4- or 5- or 6-yl; 2H-1,3-thiazin-2- or 4- or 5- or 6-yl; 6H-1,3-thiazin-2- or 4- or 5- or 6-yl; 4H-1,3-Thiazin-2- or 4- or 5- or 6-yl. Further examples of “heterocyclyl” are a partially or fully hydrogenated heterocyclic radical with 3 heteroatoms from the group N, O and S, such as, for example, 1,4,2-dioxazolidin-2- or 3- or 5-yl; 1,4,2-dioxazol-3- or 5-yl; 1,4,2-dioxazinan-2- or -3- or 5- or 6-yl; 5,6-dihydro-1,4,2-dioxazin-3- or 5- or 6-yl; 1,4,2-dioxazin-3- or 5- or 6-yl; 1,4,2-dioxazepan-2- or 3- or 5- or 6- or 7-yl; 6,7-Dihydro-5H-1,4,2-dioxazepin-3- or 5- or 6- or 7-yl; 2,3-Dihydro-7H-1,4,2-dioxazepin-2- or 3- or 5- or 6- or 7-yl; 2,3-Dihydro-5H-1,4,2-dioxazepin-2- or 3- or 5- or 6- or 7-yl; 5H-1,4,2-dioxazepin-3- or 5- or 6- or 7-yl; 7H-1,4,2-dioxazepin-3- or 5- or 6- or 7-yl. Structural examples of optionally further substituted heterocycles are also listed below: g 0,

[0003] Die oben aufgeführten Heterocyclen sind bevorzugt beispielsweise durch Wasserstoff, Halogen, Alkyl, Haloalkyl, Hydroxy, Alkoxy, Cycloalkoxy, Aryloxy, Alkoxyalkyl, Alkoxyalkoxy, Cycloalkyl, Halocycloalkyl, Aryl, Arylalkyl, Heteroaryl, Heterocyclyl, Alkenyl, Alkylcarbonyl, Cycloalkylcarbonyl, Arylcarbonyl, Heteroarylcarbonyl, Alkoxycarbonyl, Hydroxycarbonyl, Cycloalkoxycarbonyl, Cycloalkylalkoxycarbonyl, Alkoxycarbonylalkyl, Arylalkoxycarbonyl, Arylalkoxycarbonylalkyl, Alkinyl, Alkinylalkyl, Alkylalkinyl, Tris-alkylsilylalkinyl, Nitro, Amino, Cyano, Haloalkoxy, Haloalkylthio, Alkylthio, Hydrothio, Hydroxyalkyl, Oxo, Heteroarylalkoxy, Arylalkoxy, Heterocyclylalkoxy, Heterocyclylalkylthio, Heterocyclyloxy, Heterocyclylthio, Heteroaryloxy, Bis- alkylamino, Alkylamino, Cycloalkylamino, Hydroxycarbonylalkylamino, Alkoxycarbonylalkylamino, Arylalkoxycarbonylalkylamino, Alkoxycarbonylalkyl(alkyl)amino, Aminocarbonyl, Alkylaminocarbonyl, Bis-alkylaminocarbonyl, Cycloalkylaminocarbonyl,Hydroxycarbonylalkylaminocarbonyl, alkoxycarbonylalkylaminocarbonyl, arylalkoxycarbonylalkylaminocarbonyl. If a basic structure is substituted "by one or more residues" from a list of residues (= group) or a generically defined group of residues, this includes simultaneous substitution by several identical and / or structurally different residues. If it is a partially or fully saturated nitrogen heterocycle, it can be linked to the rest of the molecule via both the carbon and the nitrogen atom. Possible substituents for a substituted heterocyclic residue are the substituents listed below:Additionally, oxo and thioxo are also included. The oxo group as a substituent on a ring C atom then means, for example, a carbonyl group in the heterocyclic ring. This preferably also includes lactones and lactams. The oxo group can also occur on the hetero ring atoms, which can exist in different oxidation states, e.g., N and S, and then forms, for example, the divalent groups N(O), S(O) (also abbreviated to SO) and S(O)2 (also abbreviated to SO2) in the heterocyclic ring. In the case of -N(O)- and -S(O)- groups, both enantiomers are included. According to the invention, the term "heteroaryl" stands for heteroaromatic compounds, i.e., fully unsaturated aromatic heterocyclic compounds, preferably 5- to 7-membered rings with 1 to 4, preferably 1 or 2 identical or different heteroatoms, preferably O,S oder N. Erfindungsgemäße Heteroaryle sind beispielsweise 1H-Pyrrol-1-yl; 1H-Pyrrol-2-yl; 1H-Pyrrol- 3-yl; Furan-2-yl; Furan-3-yl; Thien-2-yl; Thien-3-yl, 1H-Imidazol-1-yl; 1H-Imidazol-2-yl; 1H-Imidazol- 4-yl; 1H-Imidazol-5-yl; 1H-Pyrazol-1-yl; 1H-Pyrazol-3-yl; 1H-Pyrazol-4-yl; 1H-Pyrazol-5-yl, 1H-1,2,3- Triazol-1-yl, 1H-1,2,3-Triazol-4-yl, 1H-1,2,3-Triazol-5-yl, 2H-1,2,3-Triazol-2-yl, 2H-1,2,3-Triazol-4-yl, 1H-1,2,4-Triazol-1-yl, 1H-1,2,4-Triazol-3-yl, 4H-1,2,4-Triazol-4-yl, 1,2,4-Oxadiazol-3-yl, 1,2,4- Oxadiazol-5-yl, 1,3,4-Oxadiazol-2-yl, 1,2,3-Oxadiazol-4-yl, 1,2,3-Oxadiazol-5-yl, 1,2,5-Oxadiazol-3-yl, Azepinyl, Pyridin-2-yl, Pyridin-3-yl, Pyridin-4-yl, Pyrazin-2-yl, Pyrazin-3-yl, Pyrimidin-2-yl, Pyrimidin-4-yl, Pyrimidin-5-yl, Pyridazin-3-yl, Pyridazin-4-yl, 1,3,5-Triazin-2-yl, 1,2,4-Triazin-3-yl, 1,2,4-Triazin-5-yl, 1,2,4-Triazin-6-yl, 1,2,3-Triazin-4-yl, 1,2,3-Triazin-5-yl, 1,2,4-, 1,3,2-, 1,3,6- und 1,2,6-Oxazinyl, Isoxazol-3-yl, Isoxazol-4-yl, Isoxazol-5-yl, 1,3-Oxazol-2-yl,1,3-oxazol-4-yl, 1,3-oxazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, 1,3-thiazol-2-yl, 1,3-thiazol-4-yl, 1,3-thiazol-5-yl, oxepinyl, thiepinyl, 1,2,4-triazolonyl and 1,2,4-diazepinyl, 2H-1,2,3,4-tetrazol-5-yl, 1H-1,2,3,4-tetrazol-5-yl, 1,2,3,4-oxatriazol-5-yl, 1,2,3,4-thiatriazol-5-yl, 1,2,3,5-oxatriazol-4-yl, 1,2,3,5-Thiatriazol-4-yl. The heteroaryl groups according to the invention can further be substituted by one or more identical or different radicals. If two adjacent carbon atoms are part of another aromatic ring, these are fused heteroaromatic systems, such as benzofused or multiply fused heteroaromatics. Preferred examples are quinolines (e.g., quinolin-2-yl, quinolin-3-yl, quinolin-4-yl, quinolin-5-yl, quinolin-6-yl, quinolin-7-yl, quinolin-8-yl); isoquinolines (e.g., isoquinolin-1-yl, isoquinolin-3-yl, isoquinolin-4-yl, isoquinolin-5-yl, isoquinolin-6-yl, isoquinolin-7-yl,Isochinolin-8-yl); Chinoxalin; Chinazolin; Cinnolin; 1,5-Naphthyridin; 1,6-Naphthyridin; 1,7-Naphthyridin; 1,8-Naphthyridin; 2,6- Naphthyridin; 2,7-Naphthyridin; Phthalazin; Pyridopyrazine; Pyridopyrimidine; Pyridopyridazine; Pteridine; Pyrimidopyrimidine. Beispiele für Heteroaryl sind auch 5- oder 6-gliedrige benzokondensierte Ringe aus der Gruppe 1H-Indol-1-yl, 1H-Indol-2-yl, 1H-Indol-3-yl, 1H-Indol-4-yl, 1H-Indol-5-yl, 1H- Indol-6-yl, 1H-Indol-7-yl, 1-Benzofuran-2-yl, 1-Benzofuran-3-yl, 1-Benzofuran-4-yl, 1-Benzofuran-5- yl, 1-Benzofuran-6-yl, 1-Benzofuran-7-yl, 1-Benzothiophen-2-yl, 1-Benzothiophen-3-yl, 1-Benzo- thiophen-4-yl, 1-Benzothiophen-5-yl, 1-Benzothiophen-6-yl, 1-Benzothiophen-7-yl, 1H-Indazol-1-yl, 1H-Indazol-3-yl, 1H-Indazol-4-yl, 1H-Indazol-5-yl, 1H-Indazol-6-yl, 1H-Indazol-7-yl, 2H-Indazol-2-yl, 2H-Indazol-3-yl, 2H-Indazol-4-yl, 2H-Indazol-5-yl, 2H-Indazol-6-yl, 2H-Indazol-7-yl, 2H-Isoindol-2- yl, 2H-Isoindol-1-yl, 2H-Isoindol-3-yl, 2H-Isoindol-4-yl, 2H-Isoindol-5-yl,2H-isoindol-6-yl; 2H-Isoindol-7-yl, 1H-Benzimidazol-1-yl, 1H-Benzimidazol-2-yl, 1H-Benzimidazol-4-yl, 1H-Benzimidazol-5-yl, 1H-Benzimidazol-6-yl, 1H-Benzimidazol-7-yl, 1,3-Benzoxazol-2-yl, 1,3-Benzoxazol-4-yl, 1,3-Benzoxazol-5-yl, 1,3-Benzoxazol-6-yl, 1,3-Benzoxazol-7-yl, 1,3-Benzthiazol-2-yl, 1,3-Benzthiazol-4-yl, 1,3-Benzthiazol-5-yl, 1,3-Benzthiazol-6-yl, 1,3-Benzthiazol-7-yl, 1,2-Benzisoxazol-3-yl, 1,2- Benzisoxazol-4-yl, 1,2-benzisoxazol-5-yl, 1,2-benzisoxazol-6-yl, 1,2-benzisoxazol-7-yl, 1,2-benzisothiazol-3-yl, 1,2-benzisothiazol-4-yl, 1,2-benzisothiazol-5-yl, 1,2-benzisothiazol-6-yl, 1,2-benzisothiazol-7-yl. The term "halogen" means, for example, fluorine, chlorine, bromine, or iodine. If the term is used for a radical, then "halogen" means, for example, a fluorine, chlorine, bromine, or iodine atom. According to the invention, "alkyl" means a straight-chain or branched, open-chain, saturated hydrocarbon radical.which is optionally mono- or polysubstituted and in the latter case is referred to as “substituted alkyl”. Preferred substituents are halogen atoms, alkoxy, haloalkoxy, cyano, alkylthio, haloalkylthio, amino or nitro groups, particular preference being given to methoxy, methyl, fluoroalkyl, cyano, nitro, fluorine, chlorine, bromine or iodine. The prefix “bis” also includes the combination of different alkyl radicals, e.g. methyl(ethyl) or ethyl(methyl). “Haloalkyl”, “-alkenyl” and “-alkynyl” mean alkyl, alkenyl or alkynyl which is partially or fully substituted by identical or different halogen atoms, e.g. monohaloalkyl (= monohaloalkyl) such as, for example, CH2CH2Cl, CH2CH2Br, CHClCH3, CH2Cl, CH2F; perhaloalkyl such as, for example, B. CCl3, CClF2, CFCl2, CF2CClF2, CF2CClFCF3; Polyhaloalkyl such as B. CH2CHFCl, CF2CClFH, CF2CBrFH,CH2CF3; The term "haloalkyl" also includes the term "fluoroalkyl." The term "perhaloalkyl" also includes the term "perfluoroalkyl." "Haloalkoxy" is, for example, OCF3, OCHF2, OCH2F, OCF2CF3, OCH2CF3, and OCH2CH2Cl; the same applies to haloalkenyl and other halogen-substituted radicals. The term "(C1-C5)-alkyl" used here as an example is a shorthand for straight-chain or branched alkyl with one to five carbon atoms, corresponding to the range specified for carbon atoms, i.e., it includes, for example, the radicals methyl, ethyl, 1-propyl, 2-propyl, 1-butyl, 2-butyl, 2-methylpropyl, tert-butyl, 1-pentyl, 2-methylbut-1-yl, 3-methylbut-1-yl, and 2,2-dimethylprop-1-yl. General alkyl radicals with a larger specified range of carbon atoms, e.g., "(C1-C6)-alkyl," correspondingly also include straight-chain or branched alkyl radicals with a larger number of carbon atoms, i.e., according to the example, also the alkyl radicals with 5 and 6 carbon atoms. Unless specifically stated,For hydrocarbon radicals such as alkyl, alkenyl, and alkynyl radicals, even in compound radicals, lower carbon skeletons, e.g., those with 1 to 6 C atoms, or for unsaturated groups with 2 to 6 C atoms, are preferred. Alkyl radicals, even in compound radicals such as alkoxy, haloalkyl, etc., are, for example, methyl, ethyl, n- or i-propyl, n-, i-, t-, or 2-butyl, pentyls, hexyls, such as n-hexyl, i-hexyl, and 1,3-dimethylbutyl, and heptyls, such as n-heptyl, 1-methylhexyl, and 1,4-dimethylpentyl. Alkenyl and alkynyl radicals have the meaning of the possible unsaturated radicals corresponding to the alkyl radicals, containing at least one double bond or triple bond. Preferred are radicals with one double bond or triple bond. The term "alkenyl" includes, in particular, straight-chain or branched open-chain hydrocarbon radicals with more than one double bond, such as 1,3-butadienyl and 1,4-pentadienyl.but also allenyl or cumulenyl residues with one or more cumulated double bonds, such as allenyl (1,2-propadienyl), 1,2-butadienyl and 1,2,3-pentatrienyl. Alkenyl means, for example, vinyl, which may optionally be substituted by other alkyl radicals, e.g. (but not limited to) (C2-C6)-alkenyl such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-Methyl-2-butenyl, 1-Methyl-3-butenyl, 2-Methyl-3-butenyl, 3-Methyl-3-butenyl, 1,1-Dimethyl-2-propenyl, 1,2-Dimethyl-1-propenyl, 1,2-Dimethyl-2-propenyl, 1-Ethyl-1-propenyl, 1-Ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-1-pentenyl, 2-methyl-1-pentenyl, 3-methyl-1-pentenyl, 4-methyl-1-pentenyl, 1-methyl-2-pentenyl,2-Methyl-2-pentenyl, 3-Methyl-2-pentenyl, 4-Methyl-2-pentenyl, 1-Methyl-3- pentenyl, 2-Methyl-3-pentenyl, 3-Methyl-3-pentenyl, 4-Methyl-3-pentenyl, 1-Methyl-4-pentenyl, 2- Methyl-4-pentenyl, 3-Methyl-4-pentenyl, 4-Methyl-4-pentenyl, 1,1-Dimethyl-2-butenyl, 1,1-Dimethyl- 3-butenyl, 1,2-Dimethyl-1-butenyl, 1,2-Dimethyl-2-butenyl, 1,2-Dimethyl-3-butenyl, 1,3-Dimethyl-1- butenyl, 1,3-Dimethyl-2-butenyl, 1,3-Dimethyl-3-butenyl, 2,2-Dimethyl-3-butenyl, 2,3-Dimethyl-1- butenyl, 2,3-Dimethyl-2-butenyl, 2,3-Dimethyl-3-butenyl, 3,3-Dimethyl-1-butenyl, 3,3-Dimethyl-2- butenyl, 1-Ethyl-1-butenyl, 1-Ethyl-2-butenyl, 1-Ethyl-3-butenyl, 2-Ethyl-1-butenyl, 2-Ethyl-2-butenyl, 2-Ethyl-3-butenyl, 1,1,2-Trimethyl-2-propenyl, 1-Ethyl-1-methyl-2-propenyl,1-Ethyl-2-methyl-1-propenyl and 1-ethyl-2-methyl-2-propenyl. The term "alkynyl" also includes, in particular, straight-chain or branched open-chain hydrocarbon radicals with more than one triple bond or with one or more triple bonds and one or more double bonds, such as 1,3-butatrienyl or 3-penten-1-yn-1-yl. (C2-C6)-alkynyl means, for example, ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl, 1-Methyl-3-pentynyl, 1-Methyl-4-pentynyl, 2-Methyl-3-pentynyl, 2-Methyl-4-pentynyl, 3-Methyl-1-pentynyl, 3-Methyl-4-pentynyl, 4-Methyl-1-pentynyl, 4-Methyl-2-pentynyl, 1,1-Di-methyl-2-butynyl, 1,1-Dimethyl-3-butynyl, 1,2-Dimethyl-3-butynyl, 2,2-Dimethyl-3-butynyl, 3,3-dimethyl-1-butynyl, 1-ethyl-2-butynyl, 1-ethyl-3-butynyl, 2-ethyl-3-butynyl, and 1-ethyl-1-methyl-2-propynyl. The term "cycloalkyl" means a carbocyclic, saturated ring system with preferably 3-8 ring carbon atoms, e.g., cyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl, which is optionally further substituted, preferably by hydrogen, alkyl, alkoxy, cyano, nitro, alkylthio, haloalkylthio, halogen, alkenyl, alkynyl, haloalkyl, amino, alkylamino, bisalkylamino, alkoxycarbonyl, hydroxycarbonyl, arylalkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, or cycloalkylaminocarbonyl. In the case of optionally substituted cycloalkyl, cyclic systems with substituents are included, including substituents with a double bond on the cycloalkyl radical, e.g., an alkylidene group such as methylidene. In the case of optionally substituted cycloalkyl, polycyclic aliphatic systems are also included.such as bicyclo[1.1.0]butan-1-yl, bicyclo[1.1.0]butan-2-yl, bicyclo[2.1.0]pentan-1-yl, bicyclo[1.1.1]pentan-1-yl, bicyclo[2.1.0]pentan-2-yl, bicyclo[2.1.0]pentan-5-yl, bicyclo[2.1.1]hexyl, Bicyclo[2.2.1]hept-2-yl, bicyclo[2.2.2]octan-2-yl, bicyclo[3.2.1]octan-2-yl, bicyclo[3.2.2]nonan-2-yl, adamantan-1-yl and adamantan-2-yl, but also systems such as. B.1,1'-Bi(cyclopropyl)-1-yl, 1,1'-Bi(cyclopropyl)-2-yl. The term "(C3-C7)-cycloalkyl" is a shorthand notation for cycloalkyl with three to seven carbon atoms, corresponding to the range for C atoms. "Cycloalkenyl" means a carbocyclic, non-aromatic, partially unsaturated ring system with preferably 4-8 C atoms, e.g., 1-cyclobutenyl, 2-cyclobutenyl, 1-cyclopentenyl, 2-cyclopentenyl, 3-cyclopentenyl, or 1-cyclohexenyl, 2-cyclohexenyl, 3-cyclohexenyl, 1,3-cyclohexadienyl, or 1,4-cyclohexadienyl, where substituents with a double bond on the cycloalkenyl radical,e.g., an alkylidene group such as methylidene. In the case of optionally substituted cycloalkenyl, the explanations for substituted cycloalkyl apply accordingly. The term "alkylidene", e.g., also in the form (C1-C, 10 )-Alkylidene, means the residue of a straight-chain or branched open-chain hydrocarbon residue that is bonded via a double bond. Naturally, only positions on the parent structure where two H atoms can be replaced by the double bond are possible as bonding sites for alkylidene; examples of residues are, for example, =CH2, =CH-CH3, =C(CH3)-CH3, =C(CH3)-C2H5, or =C(C2H5)-C2H 5.Cycloalkylidene means a carbocyclic radical bonded via a double bond. The term "alkylene", e.g. also in the form (C1-C8)-alkylene, means the radical of a straight-chain or branched open-chain hydrocarbon radical bonded to other groups at two positions. "Alkoxyalkyl" stands for an alkoxy radical bonded via an alkyl group, and "alkoxyalkoxy" means an alkoxyalkyl radical bonded via an oxygen atom, e.g. (but not limited to) methoxymethoxy, methoxyethoxy, ethoxyethoxy, methoxy-n-propyloxy. "Arylalkyl" stands for an aryl radical bonded via an alkyl group, "heteroarylalkyl" means a heteroaryl radical bonded via an alkyl group, and "heterocyclylalkyl" means a heterocyclyl radical bonded via an alkyl group. "Cycloalkylalkyl" stands for a cycloalkyl radical bonded via an alkyl group, e.g.(but not limited to) Cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl, 1-cyclopropyleth-1-yl, 2-cyclopropyleth-1-yl, 1-cyclopropylprop-1-yl, 3-cyclopropylprop-1-yl. "Arylalkenyl" means an aryl radical attached via an alkenyl group, "heteroarylalkenyl" means a heteroaryl radical attached via an alkenyl group, and "heterocyclylalkenyl" means a heterocyclyl radical attached via an alkenyl group. "Arylalkynyl" means an aryl radical attached via an alkynyl group, "heteroarylalkynyl" means a heteroaryl radical attached via an alkynyl group, and "heterocyclylalkynyl" means a heterocyclyl radical attached via an alkynyl group. According to the invention, "haloalkylthio" - alone or as part of a chemical group - stands for straight-chain or branched S-haloalkyl, preferably with 1 to 8, or with 1 to 6 carbon atoms, such as (C1-C8)-, (C1-C6)- or (C1-C4)-haloalkylthio, e.g.(but not limited to) trifluoromethylthio, pentafluoroethylthio, difluoromethyl, 2,2-difluoroeth-1-ylthio, 2,2,2-difluoroeth-1-ylthio, 3,3,3-prop-1-ylthio. “Halocycloalkyl” and “halocycloalkenyl” mean radicals substituted by the same or different halogen atoms, such as F, Cl and Br, or by haloalkyl, such as B. Trifluoromethyl or difluoromethyl partially or fully substituted cycloalkyl or cycloalkenyl, e.g. 1-fluorocycloprop-1-yl, 2-fluorocycloprop-1-yl, 2,2-difluorocycloprop-1-yl, 1-fluorocyclobut-1-yl, 1-trifluoromethylcycloprop-1-yl, 2-trifluoromethylcycloprop-1-yl, 1-chloro-cycloprop-1-yl, 2-chlorocycloprop-1-yl, 2,2-dichlorocycloprop-1-yl, 3,3-difluorocyclobutyl. In the following, only the neutral compound is mentioned and thus includes all existing forms as listed, unless a specific form of the active ingredient is relevant in a certain context, such as in the table examples below for biological activity.The herbicide / safener combinations according to the invention may contain further components, e.g., other active ingredients against harmful organisms such as harmful plants, plant-harming animals, or plant-harming fungi, in particular active ingredients from the group of herbicides other than the herbicides listed under B, fungicides, insecticides, acaricides, nematicides, and miticides and related substances, or also other types of crop protection active ingredients (e.g., resistance inducers), crop-protective active ingredients (safeners, antidotes, other than component (A)), plant growth regulators, and / or additives and / or formulation aids commonly used in crop protection. The components can be formulated and applied together (ready-to-use formulation), or they can be formulated separately and applied together, e.g., in a tank mix or in sequential application.The individual safeners of the general formula (I) contained as component (A) are also referred to below as compounds (A), active ingredients (A), components (A) or safeners (A). Accordingly, the individual herbicidal active ingredients contained as component (B) are also referred to below as compounds (B), active ingredients (B), components (B), herbicides (B) or compounds of the formula (II). An advantageous property of the inventive combination of safeners (A) and herbicides (B) is that safeners (A) and herbicides (B) are compatible with one another, i.e. they can be used together without significant chemical incompatibilities between the safener (A) and / or the herbizuids (B) occurring, which could lead to decomposition of the safener (A) or the herbicide(s) (B). This favorable compatibility also extends to the biological properties of the active ingredients when used in combination.Thus, antagonistic effects are generally not observed in the control of weeds with the herbicide / safener combinations according to the invention. The following definitions apply in formula (I) for compounds of the safener (A) and in formula (II) for compounds of the herbicide (B) and all subsequent formulas: The compounds of formula (I) or (II) can exist as stereoisomers depending on the nature and linkage of the substituents. If, for example, one or more asymmetrically substituted carbon and / or sulfur atoms are present, enantiomers and diastereomers can occur. Stereoisomers can be obtained from the mixtures obtained during production by customary separation methods, for example by chromatographic separation processes. Stereoisomers can also be selectively produced by using stereoselective reactions using optically active starting materials and / or auxiliaries.The invention also relates to all stereoisomers and mixtures thereof which are encompassed by the formula (I) or (II) but are not specifically defined. For the sake of simplicity, however, reference will always be made below to compounds of the formula (I) or (II), although this includes both the pure compounds and, where appropriate, mixtures with varying proportions of isomeric compounds. Depending on the nature of the substituents defined above, the compounds of the formula (I) or (II) have acidic properties and can form salts, optionally also internal salts or adducts, with inorganic or organic bases or with metal ions. If the compounds of the formula (I) or (II) carry hydroxyl, carboxyl or other groups which induce acidic properties, these compounds can be reacted with bases to form salts.Suitable bases include, for example, hydroxides, carbonates, bicarbonates of alkali and alkaline earth metals, especially those of sodium, potassium, magnesium, and calcium, as well as ammonia, primary, secondary, and tertiary amines with (C1-C4) alkyl groups, mono-, di-, and trialkanolamines of (C1-C4) alkanols, choline, and chlorocholine, as well as organic amines such as trialkylamines, morpholine, piperidine, or pyridine. These salts are compounds in which the acidic hydrogen is replaced by a cation suitable for agriculture, for example, metal salts, especially alkali metal salts or alkaline earth metal salts, especially sodium and potassium salts, or ammonium salts, salts with organic amines, or quaternary ammonium salts, for example with cations of the formula [NRR´R´´R´´´]. +, wherein R to R''' each independently represent an organic radical, in particular alkyl, aryl, aralkyl or alkylaryl. Also suitable are alkylsulfonium and alkylsulfoxonium salts, such as (C1-C4)-trialkylsulfonium and (C1-C4)-trialkylsulfoxonium salts. In particular, G in compounds of the formula (II) can be an agronomically acceptable metal such as copper, iron, lithium, sodium, potassium, magnesium or calcium (in particular an alkali or alkaline earth metal). The compounds of the formula (I) or (II) can be obtained by addition of a suitable inorganic or organic acid, for example mineral acids, such as HCl, HBr, H2SO4, H3PO4 or HNO3, or organic acids, e.g. B. carboxylic acids, such as formic acid, acetic acid, propionic acid, oxalic acid, lactic acid or salicylic acid or sulfonic acids, such as p-toluenesulfonic acid, form salts with a basic group, such as amino, alkylamino, dialkylamino, piperidino, morpholino or pyridino.These salts then contain the conjugate base of the acid as an anion. Suitable substituents, which are present in deprotonated form, such as sulfonic acids or carboxylic acids, can form internal salts with protonatable groups, such as amino groups. If a group is polysubstituted by radicals, this means that this group is substituted by one or more of the same or different radicals mentioned. Preferred, particularly preferred, and very particularly preferred meanings are described below for the individual safeners (A) and the herbicides (B). If the compounds can form tautomers by hydrogen shift which would not be structurally covered by the general formula (A), these tautomers are nevertheless encompassed by the definition of the compounds of the general formula (A) according to the invention, unless a specific tautomer is the subject of consideration.For example, many carbonyl compounds can exist in both the keto and the enol form, both forms being encompassed by the definition of a compound of general formula (A). The compounds of general formula (I) can exist as stereoisomers depending on the type and linkage of the substituents. The possible stereoisomers defined by their specific spatial form, such as enantiomers, diastereomers, Z and E isomers, are all encompassed by general formula (I). If, for example, one or more alkenyl groups are present, diastereomers (Z and E isomers) can occur. If, for example, one or more asymmetric carbon atoms are present, enantiomers and diastereomers can occur. Stereoisomers can be obtained from the mixtures obtained during production using conventional separation methods. Chromatographic separation can be carried out on an analytical scale to determine the enantiomeric excess or the enantiomeric concentration.of the diastereomeric excess, as well as on a preparative scale for the production of test samples for biological testing. Stereoisomers can also be prepared selectively by using stereoselective reactions using optically active starting materials and / or auxiliaries. The invention thus also relates to all stereoisomers encompassed by the general formula (I) but not indicated with their specific stereoform, as well as mixtures thereof. If the compounds are obtained as solids, purification can also be carried out by recrystallization or digestion. If individual compounds of the general formula (I) cannot be satisfactorily obtained by the routes described below, they can be prepared by derivatization of other compounds of the general formula (I).Suitable methods for the isolation, purification, and stereoisomer separation of compounds of general formula (I) include methods generally known to the person skilled in the art from analogous cases, e.g., physical processes such as crystallization, chromatography, especially column chromatography and HPLC (high-pressure liquid chromatography), distillation, optionally under reduced pressure, extraction, and other processes. Any remaining mixtures can generally be separated by chromatographic separation, e.g., on chiral solid phases. For preparative quantities or on an industrial scale, processes such as crystallization, e.g., of diastereomeric salts, which can be obtained from the diastereomer mixtures with optically active acids and, if acidic groups are present, with optically active bases, are suitable.In a first embodiment of the present invention, the herbicide / safener combination according to the invention contains, in addition to at least one component (B) as defined above, preferably a component (A) (safener (A)) of the general formula (I) or their agronomically acceptable salts according to Table 1. Table 1: IUPAC names and the structural formulas of the preferred compounds of the formula (I) (safener (A)). Compounds of formula (I) are known from the international application with the application number PCT / EP2020 / 083167 (WO2021 / 105101) and can be prepared by the processes described therein. Particularly preferred safeners (A) within the meaning of the present invention are the compounds with the numbers A1, A3, A5, A7 and A9, according to Table 1 above. In a second embodiment of the present invention, the herbicide / safener combination according to the invention preferably contains a compound A1, A3, A5, A7 and A9 according to Table 1 above or their agronomically acceptable salts [safener (A)] and preferably a compound from the group of herbicidally active ingredients of the formula (II) listed in Table 2 below [herbicide (B)], wherein R 1 , R 2 , G and Y have the meanings below and R 3 and R 6 stand for hydrogen and R 4 and R 5form a group -CH2-CH2- and form a ring with the carbon atoms to which they are attached and the group Y.

[0004]

[0005] Compounds of formula (II) are known from the international application with the application number PCT / EP2015 / 063744 (WO2015 / 197468) and can be prepared by the processes described therein. 5 In a third embodiment of the present invention, the herbicide / safener combination according to the invention, in addition to at least one component (B) as defined in Table 3 below, preferably contains a compound A1, A3, A5, A7 and A9 according to Table 1 above or their agronomically acceptable salts [safener (A)]. In the components (B) of the general formula (II) in Table 3 below, R 3 and R 6 for hydrogen and R 4 and R 5form a group -CH2-CH2- and form a ring with the carbon atoms to which they are bonded and the group Y. R 1 , R 2 , G, and Y have the meanings below. Table 3: 15 In a fourth embodiment of the present invention, the herbicide / safener combination according to the invention comprises, in addition to at least one component selected from B1, B24 and B29 as defined below, preferably a compound A1, A3, A5, A7 and A9 according to Table 1 above or their agronomically acceptable salts [Safener (A)]. B1: 4-Hydroxy-3-[2-methoxy-4-(prop-1-yn-1-yl)phenyl]bicyclo[3.2.1]oct-3-en-2-one B24: Sodium 3-[2-methoxy-4-(prop-1-yn-1-yl)phenyl]-4-oxobicyclo[3.2.1]oct-2-en-2-olate B29: 3-[2-Methoxy-4-(1-propyn-1-yl)phenyl]-4-oxobicyclo[3.2.1]oct-2-en-2-yl methyl carbonate Within the scope of the present invention, it is possible to combine the individual preferred and particularly preferred ones with one another as desired. This means that herbicidal compositions comprising safeners (A), one or more compounds of the general formula (I) or their agrochemically acceptable salts [component (A)], and (B) one or more herbicides [component (B)] are encompassed by the present invention, in which any disclosed, preferred, and particularly preferred embodiments as listed above can be combined with one another. Some binary combinations comprising a compound (A) of the general formula (I) or their agrochemically acceptable salts [safener (A)] acting as a safener, and a herbicide (B) have surprisingly proven particularly advantageous at the time of application. These are listed in Table 4 below.Table 4:. Furthermore, the herbicide / safener combinations according to the invention can be used together with other active ingredients such as fungicides, insecticides, acaricides, etc. and / or plant growth regulators or adjuvants from the group of additives commonly used in crop protection, such as adjuvants and formulation aids. Their application forms, such as formulations or tank mixes, represent herbicidal compositions (compositions). The invention therefore also relates to the herbicide / safener combinations admixed with additives commonly used in crop protection, such as adjuvants and formulation aids, and optionally other crop protection active ingredients. The invention also relates to the use of, or the application method using, the herbicide / safener combinations according to the invention as herbicides and plant growth regulators.preferably as herbicides and plant growth regulators with a synergistically effective content of the respective herbicide combination contained. For the active ingredients from group (B), the application rate is preferably in the range from 5 to 400 g ai / ha, in particular in the range from 8 to 200 g / ha, and most preferably in the range from 10 to 90 g ai / ha. The quantity ratios (A):(B) based on the weight are, depending on the effective application rates, generally in the range from 1:400 to 500:1, preferably in the range from 1:100 to 100:1, particularly preferably in the range from 1:40 to 20:1. The quantities stated are application rates (g ai / ha = grams of active substance per hectare) and thus also define the quantity ratios in a co-formulation, a premix, a tank mix or a sequential application of the combined active ingredients. The herbicide / safener combinations according to the invention may contain further components,e.g. other active substances against harmful organisms such as harmful plants, plant-harming animals or plant-harming fungi, in particular active substances from the group of fungicides, insecticides, acaricides, nematicides, miticides and related substances. Fungicidally active compounds which can be used in conjunction with the herbicide / safener combinations according to the invention are preferably commercially available active ingredients, for example (analogous to the herbicides, the compounds are generally referred to by their common names, here in the usual English notation): 1) Inhibitors of ergosterol biosynthesis, for example cyproconazole, difenoconazole, epoxiconazole, fenhexamid, fenpropidin, fenpropimorph, fenpyrazamine, fluquinconazole, flutriafol, imazalil, imazalil sulfate, ipconazole, metconazole, myclobutanil, paclobutrazol, prochloraz, propiconazole, prothioconazole, pyrisoxazole, spiroxamine, tebuconazole, tetraconazole, triadimenol, tridemorph, triticonazole, (1R,2S,5S)-5-(4-Chlorbenzyl)-2-(chlormethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclo-pentanol, (1S,2R,5R)-5-(4-Chlorbenzyl)-2-(chlormethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (2R)-2-(1-Chlorcyclopropyl)-4-[(1R)-2,2-dichlorcyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (2R)- 2-(1-Chlorcyclopropyl)-4-[(1S)-2,2-dichlorcyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (2R)-2-[4- (4-Chlorphenoxy)-2-(trifluormethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (2S)-2-(1-Chlorcyclo- propyl)-4-[(1R)-2,2-dichlorcyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (2S)-2-(1-Chlorcyclo- propyl)-4-[(1S)-2,2-dichlorcyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (2S)-2-[4-(4-Chlorphen- oxy)-2-(trifluormethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (R)-[3-(4-Chlor-2-fluorphenyl)-5- (2,4-difluorphenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (S)-[3-(4-Chlor-2-fluorphenyl)-5-(2,4- difluorphenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, [3-(4-Chlor-2-fluorphenyl)-5-(2,4-difluor- phenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, 1-({(2R,4S)-2-[2-Chlor-4-(4-chlorphenoxy)phenyl]-4- methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazol, 1-({(2S,4S)-2-[2-Chlor-4-(4-chlorphenoxy)phenyl]- 4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazol, 1-{[3-(2-Chlorphenyl)-2-(2,4-difluor- phenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl-thiocyanat, 1-{[rel(2R,3R)-3-(2-Chlorphenyl)-2-(2,4- difluorphenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl-thiocyanat, 1-{[rel(2R,3S)-3-(2-Chlorphenyl)- 2-(2,4-difluorphenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl-thiocyanat, 2-[(2R,4R,5R)-1-(2,4- Dichlorphenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thion, 2- [(2R,4R,5S)-1-(2,4-Dichlorphenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol- 3-thion, 2-[(2R,4S,5R)-1-(2,4-Dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H- 1,2,4-triazol-3-thion, 2-[(2R,4S,5S)-1-(2,4-Dichlorphenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4- dihydro-3H-1,2,4-triazol-3-thion, 2-[(2S,4R,5R)-1-(2,4-Dichlorphenyl)-5-hydroxy-2,6,6- trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thion, 2-[(2S,4R,5S)-1-(2,4-Dichlorphenyl)-5- hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thion, 2-[(2S,4S,5R)-1-(2,4- Dichlorphenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thion, 2- [(2S,4S,5S)-1-(2,4-Dichlorphenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol- 3-thion, 2-[1-(2,4-Dichlorphenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol- 3-thion, 2-[2-Chlor-4-(2,4-dichlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, 2-[2-Chlor-4- (4-chlorphenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, 2-[4-(4-Chlorphenoxy)-2-(trifluormethyl)- phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, 2-[4-(4-Chlorphenoxy)-2-(trifluormethyl)phenyl]-1-(1H- 1,2,4-triazol-1-yl)pentan-2-ol, 2-[4-(4-Chlorphenoxy)-2-(trifluormethyl)phenyl]-1-(1H-1,2,4-triazol-1- yl)propan-2-ol, 2-{[3-(2-Chlorphenyl)-2-(2,4-difluorphenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4- triazol-3-thion, 2-{[rel(2R,3R)-3-(2-Chlorphenyl)-2-(2,4-difluorphenyl)oxiran-2-yl]methyl}-2,4- dihydro-3H-1,2,4-triazol-3-thion, 2-{[rel(2R,3S)-3-(2-Chlorphenyl)-2-(2,4-difluorphenyl)oxiran-2- yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-thion, 5-(4-Chlorbenzyl)-2-(chlormethyl)-2-methyl-1-(1H- 1,2,4-triazol-1-ylmethyl)cyclopentanol, 5-(Allylsulfanyl)-1-{[3-(2-chlorphenyl)-2-(2,4- difluorphenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol, 5-(Allylsulfanyl)-1-{[rel(2R,3R)-3-(2-chlorphenyl)- 2-(2,4-difluorphenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol, 5-(Allylsulfanyl)-1-{[rel(2R,3S)-3-(2- chlorphenyl)-2-(2,4-difluorphenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol, N'-(2,5-Dimethyl-4-{[3- (1,1,2,2-tetrafluorethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamid, N'-(2,5-Dimethyl- 4-{[3-(2,2,2-trifluorethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamid, N'-(2,5- Dimethyl-4-{[3-(2,2,3,3-tetrafluorpropoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamid, N'-(2,5-Dimethyl-4-{[3-(pentafluorethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamid, N'-(2,5-Dimethyl-4-{3-[(1,1,2,2-tetrafluorethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N- methylimidoformamid, N'-(2,5-Dimethyl-4-{3-[(2,2,2-trifluorethyl)sulfanyl]phenoxy}phenyl)-N-ethyl- N-methylimidoformamid, N'-(2,5-Dimethyl-4-{3-[(2,2,3,3-tetrafluorpropyl)sulfanyl]phenoxy}phenyl)- N-ethyl-N-methylimidoformamid, N'-(2,5-Dimethyl-4-{3-[(pentafluorethyl)sulfanyl]phenoxy}phenyl)- N-ethyl-N-methylimidoformamid, N'-(2,5-Dimethyl-4-phenoxyphenyl)-N-ethyl-N- methylimidoformamid, N'-(4-{[3-(Difluormethoxy)phenyl]sulfanyl}-2,5-dimethylphenyl)-N-ethyl-N- methylimidoformamid, N'-(4-{3-[(Difluormethyl)sulfanyl]phenoxy}-2,5-dimethylphenyl)-N-ethyl-N- methylimidoformamid, N'-[5-Brom-6-(2,3-dihydro-1H-inden-2-yloxy)-2-methylpyridin-3-yl]-N-ethyl- N-methylimidoformamid, N'-{4-[(4,5-Dichlor-1,3-thiazol-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N- methylimidoformamid, N'-{5-Brom-6-[(1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N- ethyl-N-methylimidoformamid, N'-{5-Brom-6-[(1S)-1-(3,5-difluorphenyl)ethoxy]-2-methylpyridin-3- yl}-N-ethyl-N-methylimidoformamid, N'-{5-Brom-6-[(cis-4-isopropylcyclohexyl)oxy]-2- methylpyridin-3-yl}-N-ethyl-N-methylimidoformamid, N'-{5-Brom-6-[(trans-4- isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamid, N'-{5-Bromo-6-[1- (3,5-difluorphenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamid, Mefentrifluconazole, Ipfentrifluconazole. 2) Inhibitoren der Atmungskette am Komplex I oder II beispielsweise Benzovindiflupyr, Bixafen, Boscalid, Carboxin, Fluopyram, Flutolanil, Fluxapyroxad, Furametpyr, Isofetamid, Isopyrazam (anti- epimeres Enantiomer 1R,4S,9S), Isopyrazam (anti-epimeres Enantiomer 1S,4R,9R), Isopyrazam (anti- epimeres Racemat 1RS,4SR,9SR), Isopyrazam (Mischung des syn-epimeren Razemates 1RS,4SR,9RS und des anti-epimeren Razemates 1RS,4SR,9SR), Isopyrazam (syn-epimeres Enantiomer 1R,4S,9R), (2.015) Isopyrazam (syn-epimeres Enantiomer 1S,4R,9S), Isopyrazam (syn-epimeres Racemat 1RS,4SR,9RS), Penflufen, Penthiopyrad, Pydiflumetofen, Pyraziflumid, Sedaxane, 1,3-Dimethyl-N- (1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazol-4-carboxamid, 1,3-Dimethyl-N-[(3R)-1,1,3- trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazol-4-carboxamid, 1,3-Dimethyl-N-[(3S)-1,1,3-trimethyl- 2,3-dihydro-1H-inden-4-yl]-1H-pyrazol-4-carboxamid, 1-Methyl-3-(trifluormethyl)-N-[2'- (trifluormethyl)biphenyl-2-yl]-1H-pyrazol-4-carboxamid, 2-Fluor-6-(trifluoromethyl)-N-(1,1,3- trimethyl-2,3-dihydro-1H-inden-4-yl)benzamid, 3-(Difluormethyl)-1-methyl-N-(1,1,3-trimethyl-2,3- dihydro-1H-inden-4-yl)-1H-pyrazol-4-carboxamid, 3-(Difluormethyl)-1-methyl-N-[(3R)-1,1,3- trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazol-4-carboxamid, 3-(Difluormethyl)-1-methyl-N-[(3S)- 1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazol-4-carboxamid, (2.030) 3-(Difluormethyl)-N-(7- fluor-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazol-4-carboxamid, 3-(Difluor- methyl)-N-[(3R)-7-fluor-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazol-4- carboxamid, 3-(Difluoromethyl)-N-[(3S)-7-fluor-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl- 1H-pyrazol-4-carboxamid, 5,8-Difluor-N-[2-(2-fluor-4-{[4-(trifluormethyl)pyridin-2- yl]oxy}phenyl)ethyl]quinazolin-4-amin, N-(2-Cyclopentyl-5-fluorbenzyl)-N-cyclopropyl-3- (difluormethyl)-5-fluor-1-methyl-1H-pyrazol-4-carboxamid, N-(2-tert-Butyl-5-methylbenzyl)-N- cyclopropyl-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazol-4-carboxamid, N-(2-tert-Butylbenzyl)-N- cyclopropyl-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazol-4-carboxamid, N-(5-Chlor-2-ethylbenzyl)- N-cyclopropyl-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazol-4-carboxamid,N-(5-Chlor-2- isopropylbenzyl)-N-cyclopropyl-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazol-4-carboxamid, (2.039) N-[(1R,4S)-9-(Dichlormethylen)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluormethyl)-1- methyl-1H-pyrazol-4-carboxamid, N-[(1S,4R)-9-(Dichlormethylen)-1,2,3,4-tetrahydro-1,4- methanonaphthalen-5-yl]-3-(difluormethyl)-1-methyl-1H-pyrazol-4-carboxamid, N-[1-(2,4- Dichlorphenyl)-1-methoxypropan-2-yl]-3-(difluormethyl)-1-methyl-1H-pyrazol-4-carboxamid, N-[2- Chlor-6-(trifluormethyl)benzyl]-N-cyclopropyl-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazol-4- carboxamid, N-[3-Chlor-2-fluor-6-(trifluormethyl)benzyl]-N-cyclopropyl-3-(difluormethyl)-5-fluor-1- methyl-1H-pyrazol-4-carboxamid, N-[5-Chlor-2-(trifluormethyl)benzyl]-N-cyclopropyl-3- (difluormethyl)-5-fluor-1-methyl-1H-pyrazol-4-carboxamid, N-Cyclopropyl-3-(difluormethyl)-5-fluor- 1-methyl-N-[5-methyl-2-(trifluormethyl)benzyl]-1H-pyrazol-4-carboxamid,N-Cyclopropyl-3- (difluormethyl)-5-fluor-N-(2-fluor-6-isopropylbenzyl)-1-methyl-1H-pyrazol-4-carboxamid, N- Cyclopropyl-3-(difluormethyl)-5-fluor-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1H-pyrazol-4- carboxamid, N-Cyclopropyl-3-(difluormethyl)-5-fluor-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazol-4- carbothioamid, N-Cyclopropyl-3-(difluoromethyl)-5-fluor-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazol- 4-carboxamid, N-Cyclopropyl-3-(difluormethyl)-5-fluor-N-(5-fluor-2-isopropylbenzyl)-1-methyl-1H- pyrazol-4-carboxamid, N-Cyclopropyl-3-(difluormethyl)-N-(2-ethyl-4,5-dimethylbenzyl)-5-fluor-1- methyl-1H-pyrazol-4-carboxamid, N-Cyclopropyl-3-(difluormethyl)-N-(2-ethyl-5-fluorbenzyl)-5-fluor- 1-methyl-1H-pyrazol-4-carboxamid, N-Cyclopropyl-3-(difluormethyl)-N-(2-ethyl-5-methylbenzyl)-5- fluor-1-methyl-1H-pyrazole-4-carboxamid, N-Cyclopropyl-N-(2-cyclopropyl-5-fluorbenzyl)-3- (difluormethyl)-5-fluor-1-methyl-1H-pyrazole-4-carboxamid,N-Cyclopropyl-N-(2-cyclopropyl-5- methylbenzyl)-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazole-4-carboxamid, N-Cyclopropyl-N-(2- cyclopropylbenzyl)-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazole-4-carboxamid. 3) Inhibitoren der Atmungskette am Komplex III, beispielsweise Ametoctradin, Amisulbrom, Azoxystrobin, Coumethoxystrobin, Coumoxystrobin, Cyazofamid, Dimoxystrobin, Enoxastrobin, Famoxadon, Fenamidon, Flufenoxystrobin, Fluoxastrobin, Kresoxim-Methyl, Metominostrobin, Orysastrobin, Picoxystrobin, Pyraclostrobin, Pyrametostrobin, Pyraoxystrobin, Trifloxystrobin (3.021) (2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-Fluor-2-phenylvinyl]oxy}phenyl)ethyliden]amino}oxy)methyl]- phenyl}-2-(methoxyimino)-N-methylacetamid, (2E,3Z)-5-{[1-(4-Chlorphenyl)-1H-pyrazol-3-yl]oxy}-2- (methoxyimino)-N,3-dimethylpent-3-enamid, (2R)-2-{2-[(2,5-Dimethylphenoxy)methyl]phenyl}-2- methoxy-N-methylacetamid, (2S)-2-{2-[(2,5-Dimethylphenoxy)methyl]phenyl}-2-methoxy-N- methylacetamid, (3S,6S,7R,8R)-8-Benzyl-3-[({3-[(isobutyryloxy)methoxy]-4-methoxypyridin-2- yl}carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl-2-methylpropanoat, 2-{2-[(2,5- Dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamid, N-(3-Ethyl-3,5,5- trimethylcyclohexyl)-3-formamido-2-hydroxybenzamid, (2E,3Z)-5-{[1-(4-Chlor-2-fluorphenyl)-1H- pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamid, Methyl {5-[3-(2,4-dimethylphenyl)- 1H-pyrazol-1-yl]-2-methylbenzyl}carbamate. 4) Inhibitoren der Mitose und Zellteilung, beispielsweise Carbendazim, Diethofencarb, Ethaboxam, Fluopicolid, Pencycuron, Thiabendazol, Thiophanat-Methyl, Zoxamid, 3-Chlor-4-(2,6-difluorphenyl)-6- methyl-5-phenylpyridazin, 3-Chlor-5-(4-chlorphenyl)-4-(2,6-difluorphenyl)-6-methylpyridazin, 3- Chlor-5-(6-chlorpyridin-3-yl)-6-methyl-4-(2,4,6-trifluorphenyl)pyridazin, 4-(2-Brom-4-fluorphenyl)-N- (2,6-difluorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, 4-(2-Brom-4-fluorphenyl)-N-(2-brom-6- fluorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin,4-(2-Brom-4-fluorphenyl)-N-(2-bromphenyl)-1,3- dimethyl-1H-pyrazol-5-amin, 4-(2-Brom-4-fluorphenyl)-N-(2-chlor-6-fluorphenyl)-1,3-dimethyl-1H- pyrazol-5-amin, (4.016) 4-(2-Brom-4-fluorphenyl)-N-(2-chlorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, 4-(2-Brom-4-fluorphenyl)-N-(2-fluorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, 4-(2-Chlor-4- fluorphenyl)-N-(2,6-difluorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, 4-(2-Chlor-4-fluorphenyl)-N-(2- chlor-6-fluorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, 4-(2-Chlor-4-fluorphenyl)-N-(2-chlorphenyl)- 1,3-dimethyl-1H-pyrazol-5-amin, 4-(2-Chlor-4-fluorphenyl)-N-(2-fluorphenyl)-1,3-dimethyl-1H- pyrazol-5-amin, 4-(4-Chlorphenyl)-5-(2,6-difluorphenyl)-3,6-dimethylpyridazin, N-(2-Brom-6- fluorphenyl)-4-(2-chlor-4-fluorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, N-(2-Bromphenyl)-4-(2-chlor- 4-fluorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, N-(4-Chlor-2,6-difluorphenyl)-4-(2-chlor-4-fluor- phenyl)-1,3-dimethyl-1H-pyrazol-5-amine. 5) Compounds capable of multisite activity, for example Bordeaux mixture, captafol, captan, chlorothalonil, copper hydroxide, copper naphthenate, copper oxide, copper oxychloride, copper(2+) sulfate, dithianone, dodine, folpet, mancozeb, maneb, metiram, zinc metiram, copper oxine, propineb, sulfur and sulfur preparations including calcium polysulfide, thiram, zineb, ziram, 6-ethyl-5,7-dioxo-6,7-dihydro-5H-pyrrolo[3',4':5,6][1,4]dithiino[2,3-c][1,2]thiazole-3-carbonitrile. 6) Compounds capable of triggering host defenses, for example, acibenzolar-S-methyl, isotianil, probenazole, tiadinil. 7) Inhibitors of amino acid and / or protein biosynthesis, for example, cyprodinil, kasugamycin, kasugamycin hydrochloride hydrate, oxytetracycline, pyrimethanil, 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline. (8) Inhibitors of ATP production, for example, silthiofam. 9) Inhibitors of cell wall synthesis.for example, benthiavalicarb, dimethomorph, flumorph, iprovalicarb, mandipropamid, pyrimorph, valifenalate, (2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one, (2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one. 10) Inhibitors of lipid and membrane synthesis, for example, propamocarb, propamocarb hydrochloride, tolclofos-methyl. 11) Inhibitors of melanin biosynthesis, for example, tricyclazole, 2,2,2-trifluoroethyl-{3-methyl-1-[(4-methylbenzoyl)amino]butan-2-yl}carbamate. 12) Nucleic acid synthesis inhibitors, for example, benalaxyl, benalaxyl-M (kiralaxyl), metalaxyl, metalaxyl-M (mefenoxam). 13) Signal transduction inhibitors, for example, fludioxonil, iprodione, procymidone, proquinazid, quinoxyfen, vinclozolin. 14) Compounds that can act as uncouplers, for example, fluazinam, meptyldinocap. 15) Other compounds, for example, abscisic acid, benthiazole, bethoxazine, capsimycin.Carvon, Chinomethionat, Cufraneb, Cyflufenamid, Cymoxanil, Cyprosulfamid, Flutianil, Fosetyl-Aluminium, Fosetyl-Calcium, Fosetyl-Natrium, Methylisothiocyanat, Metrafenon, Mildiomycin, Natamycin, Nickel- Dimethyldithiocarbamat, Nitrothal-Isopropyl, Oxamocarb, Oxathiapiprolin, Oxyfenthiin, Pentachlorphenol und Salze, Phosphonsäure und deren Salze, Propamocarb-fosetylat, Pyriofenone (Chlazafenone), Tebufloquin, Tecloftalam, Tolnifanide, 1-(4-{4-[(5R)-5-(2,6-Difluorphenyl)-4,5- dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluormethyl)-1H-pyrazol-1- yl]ethanon, 1-(4-{4-[(5S)-5-(2,6-Difluorphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2- yl}piperidin-1-yl)-2-[5-methyl-3-(trifluormethyl)-1H-pyrazol-1-yl]ethanon, 2-(6-Benzylpyridin-2- yl)quinazolin, 2,6-Dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c']dipyrrol-1,3,5,7(2H,6H)-tetron, 2-[3,5- Bis(difluormethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-in-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol- 3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanon, 2-[3,5-Bis(difluormethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2- chlor-6-(prop-2-in-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1- yl]ethanon, 2-[3,5-Bis(difluormethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluor-6-(prop-2-in-1- yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanon, 2-[6-(3-Fluor-4- methoxyphenyl)-5-methylpyridin-2-yl]quinazolin, 2-{(5R)-3-[2-(1-{[3,5-Bis(difluormethyl)-1H- pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorphenyl methanesulfonat, 2-{(5S)-3-[2-(1-{[3,5-Bis(difluormethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3- thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorphenyl methanesulfonat, 2-{2-[(7,8-Difluor-2- methylquinolin-3-yl)oxy]-6-fluorphenyl}propan-2-ol, 2-{2-Fluor-6-[(8-fluor-2-methylquinolin-3- yl)oxy]phenyl}propan-2-ol, 2-{3-[2-(1-{[3,5-Bis(difluormethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)- 1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorphenyl-methansulfonat, 2-{3-[2-(1-{[3,5- Bis(difluormethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5- yl}phenyl methanesulfonat, 2-Phenylphenol und deren Salze, 3-(4,4,5-Trifluor-3,3-dimethyl-3,4- dihydroisoquinolin-1-yl)quinolin, 3-(4,4-Difluor-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinolin, 4- Amino-5-fluorpyrimidin-2-ol (Tautomere Form: 4-Amino-5-fluorpyrimidin-2(1H)-on), 4-Oxo-4-[(2- phenylethyl)amino]buttersäure, 5-Amino-1,3,4-thiadiazol-2-thiol, 5-Chlor-N'-phenyl-N'-(prop-2-yn-1- yl)thiophen-2-sulfonohydrazid, 5-Fluor-2-[(4-fluorbenzyl)oxy]pyrimidin-4-amin, 5-Fluor-2-[(4- methylbenzyl)oxy]pyrimidin-4-amin, 9-Fluor-2,2-dimethyl-5-(quinolin-3-yl)-2,3-dihydro-1,4- benzoxazepin, But-3-yn-1-yl-{6-[({[(Z)-(1-methyl-1H-tetrazol-5-yl)(phenyl)methylen]amino}oxy)- methyl]pyridin-2-yl}carbamat, Ethyl-(2Z)-3-amino-2-cyano-3-phenylacrylat, Phenazin-1-carbonsäure, Propyl 3,4,5-trihydroxybenzoat, Quinolin-8-ol,Quinolin-8-ol sulfate (2:1), tert-Butyl {6-[({[(1-methyl- 1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate, 5-fluoro-4-imino-3-methyl-1)sulfonyl]-3,4-dihydropyrimidin-2(1H)-one. Preferred fungicides are selected from the group consisting of benalaxyl, bitertanol, bromuconazole, captafol, carbendazim, carpropamid, cyazofamid, cyproconazole, diethofencarb, edifenphos, fenpropimorph, fentine, fluquinconazole, fosetyl, fluoroimide, folpet, iminoctadine, iprodionem, iprovalicarb, kasugamycin, maneb, nabam, pencycuron, prochloraz, propamocarb, propineb, pyrimethanil, sprioxamine, quintozene, tebuconazole, tolylfluanid, triadimefon, triadimenol, trifloxystrobin, zineb. Insecticides, acaricides, nematicides, miticides and related active substances are, for example (analogous to herbicides and fungicides, the compounds are referred to by their common names where possible, here in the usual English spelling): (1) Acetylcholinesterase (AChE) inhibitors,vorzugsweise Carbamate ausgewählt aus Alanycarb, Aldicarb, Bendiocarb, Benfuracarb, Butocarboxim, Butoxycarboxim, Carbaryl, Carbofuran, Carbosulfan, Ethiofencarb, Fenobucarb, Formetanate, Furathiocarb, Isoprocarb, Methiocarb, Methomyl, Metolcarb, Oxamyl, Pirimicarb, Propoxur, Thiodicarb, Thiofanox, Triazamate, Trimethacarb, XMC und Xylylcarb, oder Organophosphate ausgewählt aus Acephat, Azamethiphos, Azinphos-ethyl, Azinphos- methyl, Cadusafos, Chlorethoxyfos, Chlorfenvinphos, Chlormephos, Chlorpyrifos-methyl, Coumaphos, Cyanophos, Demeton-S-methyl, Diazinon, Dichlorvos / DDVP, Dicrotophos, Dimethoat, Dimethylvinphos, Disulfoton, EPN, Ethion, Ethoprophos, Famphur, Fenamiphos, Fenitrothion, Fenthion, Fosthiazat, Heptenophos, Imicyafos, Isofenphos, Isopropyl-O-(methoxyaminothio- phosphoryl)salicylat, Isoxathion, Malathion, Mecarbam, Methamidophos, Methidathion, Mevinphos, Monocrotophos, Naled, Omethoate, Oxydemeton-methyl, Parathion-methyl, Phenthoat, Phorat, Phosalon, Phosmet,Phosphamidone, Phoxim, Pirimiphos-methyl, Profenofos, Propetamphos, Prothiofos, Pyraclofos, Pyridaphenthion, Quinalphos, Sulfotep, Tebupirimfos, Temephos, Terbufos, Tetrachlorvinphos, Thiometon, Triazophos, Triclorfon, and Vamidothion. (2) GABA-gated chloride channel blockers, preferably cyclodiene organochlorines selected from chlordane and endosulfan, or phenylpyrazoles (fiprols) selected from ethiprol and fipronil. (3) sodium channel modulators, preferably pyrethroids selected from acrinathrin, allethrin, d-cis-trans-allethrin, d-trans-allethrin, bifenthrin, bioallethrin, bioallethrin-S-cyclopentenyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, Cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin [(1R)-trans isomer], deltamethrin, empenthrin [(EZ)-(1R) isomer], esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin,Tau-fluvalinate, halfenprox, imiprothrin, kadethrin, momfluorothrin, permethrin, phenothrin [(1R)-trans isomer], prallethrin, pyrethrins (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethrin, tetramethrin [(1R)-isomer], tralomethrin, and transfluthrin, or DDT or methoxychlor. (4) Competitive modulators of the nicotinic acetylcholine receptor (nAChR), preferably neonicotinoids selected from acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid, and thiamethoxam, or nicotine, or sufoximines selected from sulfoxaflor, or butenolides selected from flupyradifurone. (5) Allosteric modulators of the nicotinic acetylcholine receptor (nAChR), preferably spinosyns selected from spinetoram and spinosad. (6) Allosteric modulators of the glutamate-dependent chloride channel (GluCl), preferably avermectins / milbemycins selected from abamectin, emamectin benzoate, lepimectin, and milbemectin. (7) Juvenile hormone mimetics,preferably juvenile hormone analogues selected from hydroprene, kinoprene and methoprene, or fenoxycarb or pyriproxyfen. (8) Various non-specific (multi-site) inhibitors, preferably alkyl halides selected from methyl bromide and other alkyl halides, or chloropicrin or sulfuryl fluoride or borax or tartar emetic or methyl isocyanate generators selected from diazomet and metam. (9) TRPV channel modulators of chordotonal organs selected from pymetrozine and pyrifluquinazone. (10) Mite growth inhibitors selected from clofentezine, hexythiazox, diflovidazine and etoxazole. (11) Microbial disruptors of the insect intestinal membrane selected from Bacillus thuringiensis subspecies israelensis, Bacillus sphaericus, Bacillus thuringiensis subspecies aizawai, Bacillus thuringiensis subspecies kurstaki, Bacillus thuringiensis subspecies tenebrionis and Bt plant proteins selected from Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, VIP3A, mCry3A, Cry3Ab,Cry3Bb and Cry34Ab1 / 35Ab1. (12) Inhibitors of mitochondrial ATP synthase, preferably ATP disruptors selected from diafenthiuron, or organotin compounds selected from azocyclotin, cyhexatin, and fenbutatin oxide, or propargite or tetradifon. (13) Uncouplers of oxidative phosphorylation by disrupting the proton gradient selected from chlorfenapyr, DNOC, and sulfluramide. (14) Blockers of the nicotinic acetylcholine receptor channel selected from bensultap, cartap hydrochloride, thiocyclam, and thiosultap sodium. (15) Chitin biosynthesis inhibitors, type 0, selected from bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, and triflumuron. (16) Chitin biosynthesis inhibitors, type 1, selected from buprofezin. (17) Moulting disruptor (particularly in dipterans, i.e., flies) selected from cyromazine. (18) Ecdysone receptor agonists selected from chromafenozide, halofenozide,Methoxyfenozide and tebufenozide. (19) Octopamine receptor agonists selected from amitraz. (20) Mitochondrial complex III electron transport inhibitors selected from hydramethylnon, acequinocyl, and fluacrypyrim. (21) Mitochondrial complex I electron transport inhibitors, preferably METI acaricides selected from fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad, and tolfenpyrad, or rotenone (Derris). (22) Voltage-gated sodium channel blockers selected from indoxacarb and metaflumizone. (23) Acetyl-CoA carboxylase inhibitors, preferably tetronic and tetramic acid derivatives selected from spirodiclofen, spiromesifen, and spirotetramat. (24) Inhibitors of mitochondrial complex IV electron transport, preferably phosphines selected from aluminum phosphide, calcium phosphide, phosphine, and zinc phosphide, or cyanides selected from calcium cyanide, potassium cyanide, and sodium cyanide. (25) Inhibitors of mitochondrial complex II electron transport,preferably beta-ketonitrile derivatives selected from cyenopyrafen and cyflumetofen, or carboxanilides selected from pyflubumide. (28) Ryanodine receptor modulators, preferably diamides selected from chlorantraniliprole, cyantraniliprole, and flubendiamide. (29) Modulators of chordotonal organs (with undefined target structure) selected from flonicamid. (30) further active ingredients selected from Acynonapyr, Afidopyropen, Afoxolaner, Azadirachtin, Benclothiaz, Benzoximate, Benzpyrimoxane, Bifenazate, Broflanilide, Bromopropylate, Quinomethionate, Chloroprallethrin, Cryolite, Cyclaniliprol, Cycloxapride, Cyhalodiamide, Dicloromezotiaz, Dicofol, epsilon-Metofluthrin, epsilon-Momfluthrin, Flometoquin, Fluazaindolizine, Fluensulfone, Flufenerim, Flufenoxystrobin, Flufiprol, Fluhexafon, Fluopyram, Flupyrimine, Fluralaner, Fluxametamide, Fufenozide, Guadipyr, Heptafluthrin, Imidaclothiz, Iprodione, kappa-Bifenthrin, kappa-Tefluthrin, Lotilaner, Meperfluthrin, Oxazosulfyl, Paichongding, Pyridalyl, Pyrifluquinazone,Pyriminostrobin, spirobudiclovir, spiropidione, tetramethylfluthrin, tetraniliprol, tetrachloroantraniliprole, tigolaner, tioxazafen, thiofluoximate, triflumezopyrim and iodomethane; Furthermore, preparations based on Bacillus firmus (I-1582, BioNeem, Votivo), as well as the following compounds: 1-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine (known from WO2006 / 043635) (CAS 885026-50-6), {1'-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]-5-fluorospiro[indol-3,4'-piperidin]-1(2H)-yl}(2-chloropyridin-4-yl)methanone (known from WO2003 / 106457) (CAS 637360-23-7), 2-Chloro-N-[2-{1-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]piperidin-4-yl}-4-(trifluoromethyl)phenyl]isonicotinamide (known from WO2006 / 003494) (CAS 872999-66-1), 3-(4-chloro- 2,6-dimethylphenyl)-4-hydroxy-8-methoxy-1,8-diazaspiro[4.5]dec-3-en-2-one (known from WO 2010052161) (CAS 1225292-17-0), 3-(4-chloro-2, 6-dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-yl-ethyl carbonate (known from EP 2647626) (CAS-1440516-42-6), 4-(But-2-yn-1-yloxy)-6-(3,5-dimethylpiperidin-1-yl)-5-fluoropyrimidine (known from WO2004 / 099160) (CAS 792914-58-0), PF1364 (known from JP2010 / 018586) (CAS-Reg.No.1204776-60-2), (3E)-3-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-1,1,1-trifluoropropan-2-one (known from WO2013 / 144213) (CAS 1461743-15-6), N-[3-(benzylcarbamoyl)-4-chlorophenyl]-1-methyl-3-(pentafluoroethyl)-4-(trifluoromethyl)-1H-pyrazole-5-carboxamide (known from WO2010 / 051926) (CAS 1226889-14-0), 5- Bromo-4-chloro-N-[4-chloro-2-methyl-6-(methylcarbamoyl)phenyl]-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamide (known from CN103232431) (CAS 1449220-44-3), 4-[5-(3,5-dichlorophenyl)-4,5-dihydro- and 4-[(5S)-5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluormethyl)-3-isoxazolyl]-2- methyl-N-(cis-1-oxido-3-thietanyl)benzamid (bekannt aus WO 2013 / 050317 A1) (CAS 1332628-83-7), N-[3-Chlor-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluorpropyl)sulfinyl]propanamid, (+)- N-[3-Chlor-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluorpropyl)sulfinyl]propanamid und (-)-N-[3-Chlor-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluorpropyl)sulfinyl]propanamid (bekannt aus WO 2013 / 162715 A2, WO 2013 / 162716 A2, US 2014 / 0213448 A1) (CAS 1477923-37-7), 5-[[(2E)-3-Chlor-2-propen-1-yl]amino]-1-[2,6-dichlor-4-(trifluormethyl)phenyl]-4- [(trifluormethyl)sulfinyl]-1H-pyrazol-3-carbonitrile (bekannt aus CN 101337937 A) (CAS 1105672-77- 2), 3-Brom-N-[4-chlor-2-methyl-6-[(methylamino)thioxomethyl]phenyl]-1-(3-chlor-2-pyridinyl)-1H- pyrazol-5-carboxamid, (Liudaibenjiaxuanan, bekannt aus CN 103109816 A) (CAS 1232543-85-9); N- [4-Chlor-2-[[(1,1-dimethylethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chlor-2-pyridinyl)-3- (fluormethoxy)-1H-pyrazol-5-carboxamid (bekannt aus WO 2012 / 034403 A1) (CAS 1268277-22-0), N- [2-(5-Amino-1,3,4-thiadiazol-2-yl)-4-chlor-6-methylphenyl]-3-brom-1-(3-chlor-2-pyridinyl)-1H- pyrazol-5-carboxamid (bekannt aus WO 2011 / 085575 A1) (CAS 1233882-22-8), 4-[3-[2,6-Dichlor-4- [(3,3-dichlor-2-propen-1-yl)oxy]phenoxy]propoxy]-2-methoxy-6-(trifluormethyl)pyrimidin (bekannt aus CN 101337940 A) (CAS 1108184-52-6); (2E)- und 2(Z)-2-[2-(4-Cyanophenyl)-1-[3- (trifluormethyl)phenyl]ethyliden]-N-[4-(difluormethoxy)phenyl]hydrazincarboxamid (bekannt aus CN 101715774 A) (CAS 1232543-85-9); Cyclopropancarbonsäure-3-(2,2-dichlorethenyl)-2,2-dimethyl-4- (1H-benzimidazol-2-yl)phenylester (bekannt aus CN 103524422 A) (CAS 1542271-46-4); (4aS)-7- Chlor-2,5-dihydro-2-[[(methoxycarbonyl)[4-[(trifluormethyl)thio]phenyl]amino]carbonyl]indeno[1,2- e][1,3,4]oxadiazin-4a(3H)-carbonsäuremethylester (bekannt aus CN 102391261 A) (CAS 1370358-69- 2); 6-Desoxy-3-O-ethyl-2,4-di-O-methyl-1-[N-[4-[1-[4-(1,1,2,2,2-pentafluorethoxy)phenyl]-1H-1,2,4- triazol-3-yl]phenyl]carbamat]-α-L-mannopyranose (bekannt aus US 2014 / 0275503 A1) (CAS 1181213- 14-8); 8-(2-Cyclopropylmethoxy-4-trifluormethylphenoxy)-3-(6-trifluormethylpyridazin-3-yl)-3- azabicyclo[3.2.1]octan (CAS 1253850-56-4), (8-anti)-8-(2-Cyclopropylmethoxy-4- trifluormethylphenoxy)-3-(6-trifluormethylpyridazin-3-yl)-3-azabicyclo[3.2.1]octan (CAS 933798-27- 7), (8-syn)-8-(2-Cyclopropylmethoxy-4-trifluormethylphenoxy)-3-(6-trifluormethylpyridazin-3-yl)-3- azabicyclo[3.2.1]octan (bekannt aus WO 2007040280 A1, WO 2007040282 A1) (CAS 934001-66-8), N-[3-Chlor-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluorpropyl)thio]-propanamid (bekannt aus WO 2015 / 058021 A1,WO 2015 / 058028 A1) (CAS 1477919-27-9) and N-[4-(aminothioxomethyl)-2-methyl-6-[(methylamino)carbonyl]phenyl]-3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide (known from CN 103265527 A) (CAS 1452877-50-7), 5-(1,3-Dioxan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methoxy]-pyrimidine (known from WO 2013 / 115391 A1) (CAS 1449021-97-9), 3-(4-chloro-2,6-dimethylphenyl)-8-methoxy-1-methyl-1,8-diazaspiro[4.5]decane-2,4-dione (known from WO 2014 / 187846 A1) (CAS 1638765-58-8), 3-(4-chloro-2,6-dimethylphenyl)-8-methoxy-1-methyl- 2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-yl-carboxylic acid ethyl ester (known from WO 2010 / 066780 A1, WO 2011151146 A1) (CAS 1229023-00-0), 4-[(5S)-5-(3,5-Dichloro-4-fluorophenyl)-4,5-dihydro-5- (trifluoromethyl)-3-isoxazolyl]-N-[(4R)-2-ethyl-3-oxo-4-isoxazolidinyl]-2-methylbenzamide (known from WO 2011 / 067272, WO2013 / 050302) (CAS 1309959-62-3). Insecticides that can preferably be used together with the herbicide / safener combinations according to the invention are:are, for example, the following: Acetamiprid, Acrinathrin, Aldicarb, Amitraz, Acinphos-methyl, Cyfluthrin, Carbaryl, Cypermethrin, Deltamethrin, Endosulfan, Ethoprophos, Fenamiphos, Fenthion, Fipronil, Imidacloprid, Methamidophos, Methiocarb, Niclosamide, Oxydemeton-methyl, Prothiophos, Silafluofen, Thiacloprid, Thiodicarb, Tralomethrin, Triazophos, Trichlorfon, Triflumuron, Terbufos, Fonofos, Phorate, Chlorpyriphos, Carbofuran, Tefluthrin. The herbicide / safener combinations according to the invention are preferably suitable for controlling undesirable plant growth in economically important crops such as wheat (durum and soft wheat), maize, soybeans, sugar beet, sugar cane, cotton, rice, beans (such as, for example, bush beans and horse beans), flax, barley, oats, rye, triticale,Potato and millet (sorghum). The herbicide / safener combinations according to the invention can be applied jointly or separately to the plants (e.g., harmful plants such as monocotyledonous or dicotyledonous weeds or undesirable crops), the seeds (e.g., grains, seeds, or vegetative propagating organs such as tubers or shoot parts with buds), or the area on which the plants grow (e.g., the cultivated area). The herbicide and the safener can be formulated and applied together (ready-to-use formulation) or they can be formulated separately and applied together, e.g., in a tank mix or in a sequential application. The herbicide / safener combinations can be applied pre-sowing (if necessary, also by incorporation into the soil),Pre-emergence or post-emergence applications are preferred. Application is preferably carried out using the early post-sowing pre-emergence method or the post-emergence method against weeds that have not yet emerged or have already emerged. Application can also be integrated into weed management systems with divided, multiple applications (sequential applications). Some examples of monocotyledonous and dicotyledonous weed flora that can be controlled by the herbicide / safener combinations according to the invention are given, without implying a restriction to specific species. On the monocot weed side, for example Aegilops, Agropyron, Agrostis, Alopecurus, Apera, Avena, Brachicaria, Bromus, Cynodon, Dactyloctenium, Digitaria, Echinochloa, Eleocharis, Eleusine, Eragrostis, Eriochloa, Festuca, Fimbristylis, Imperata, Ischaemum, Heteranthera, Imperata, Ischaemum, Leptochloa, Lolium, Monochoria,Panicum, Paspalum, Phalaris, Phleum, Poa, Rottboellia, Sagittaria, Scirpus, Setaria, Sorghum, Sphenoclea and Cyperus species are included in the annual group. In the case of dicotyledonous weed species, the spectrum of activity extends to species such as Abutilon, Amaranthus, Ambrosia, Anoda, Anthemis, Aphanes, Artemisia, Atriplex, Bellis, Bidens, Capsella, Carduus, Cassia, Centaurea, Chenopodium, Cirsium, Convolvulus, Datura, Desmodium, Emex, Erodium, Erysimum, Euphorbia, Galeopsis, Galinsoga, Galium, Geranium, Hibiscus, Ipomoea, Kochia, Lamium, Lepidium, Lindernia, Matricaria, Mentha, Mercurialis, Mullugo, Myosotis, Papaver, Pharbitis, Plantago, Polygonum, Portulaca, Ranunculus, Raphanus, Rorippa, Rotala, Rumex, Salsola, Senecio, Sesbania, Sida, Sinapis, Solanum, Sonchus, Sphenoclea, Stellaria, Taraxacum, Thlaspi, Trifolium, Urtica, Veronica, Viola, Xanthium. If the herbicide / safener combinations according to the invention are applied to the soil surface before germination,This either completely prevents the emergence of weed seedlings, or the weeds grow to the cotyledon stage, but then cease growth and finally die completely after three to four weeks. When the herbicide / safener combinations are applied post-emergence to the green parts of the plant, growth stops after treatment, and the weeds remain at the growth stage present at the time of application or die completely after a certain period.so that weed competition harmful to the crops is eliminated very early and sustainably. The crops, however, are not or only slightly affected in their development by the application of the herbicide / safener combination. The herbicide / safener combinations according to the invention are characterized by a rapid onset and long-lasting herbicidal effect. The rainfastness of the active ingredients in the combinations according to the invention is generally favorable. A particular advantage is that the effective dosages of components (A) and (B) used in the herbicide / safener combinations can be adjusted so low that their soil effect is optimally low. This makes their use possible not only in sensitive crops,but groundwater contamination is practically avoided. Economically important crops for the application of the herbicide / safener combinations according to the invention include, for example, dicotyledonous crops of the genera Arachis, Beta, Brassica, Cucumis, Cucurbita, Helianthus, Daucus, Glycine, Gossypium, Ipomoea, Lactuca, Linum, Lycopersicon, Nicotiana, Phaseolus, Pisum, Solanum, Vicia, or monocotyledonous crops of the genera Allium, Ananas, Asparagus, Avena, Hordeum, Oryza, Panicum, Saccharum, Secale, Sorghum, Triticale, Triticum and Zea. The herbicide / safener combinations according to the invention can preferably also be used in transgenic crops which are effective against growth substances or against herbicides which inhibit essential plant enzymes, e.g. B. Acetolactate synthases (ALS), EPSP synthases, glutamine synthases (GS), protoporphyrinogen IX oxidase (PPO), or hydroxyphenylpyruvate dioxygenases (HPPD), respectively against herbicides from the group of sulfonylureas, glyphosates,Glufosinate or benzoyl isoxazole and analogous active ingredients. The herbicide / safener combinations according to the invention can be prepared either as mixed formulations of components (A) and (B), optionally with further active ingredients, additives and / or customary formulation auxiliaries, which are then applied diluted with water in the usual way, or as so-called tank mixes by jointly diluting the separately formulated or partially separately formulated components with water. The herbicide / safener combinations according to the invention can be formulated in various ways, depending on the biological and / or chemical-physical parameters specified. General formulation options include, for example: wettable powders (WP), water-soluble powders (SP), emulsifiable concentrates (EC), water-soluble concentrates, aqueous solutions (SL),Emulsions (EW) such as oil-in-water and water-in-oil emulsions, sprayable solutions or emulsions, oil- or water-based dispersions, oil dispersions (OD), suspoemulsions, suspension concentrates (SC), oil-miscible solutions, capsule suspensions (CS), dusts (DP), seed dressings, granules for soil or broadcast application, granules (GR) in the form of microgranules, spray granules, coating granules, and adsorption granules, water-dispersible granules (WG), water-soluble granules (SG), ULV formulations, microcapsules, or waxes. The invention therefore also relates to herbicidal and plant growth regulating agents containing the herbicide / safener combinations according to the invention. The individual formulation types are known in principle and are described, for example, in: Winnacker-Küchler, "Chemische Technologie," Volume 7, C. Hanser Verlag, Munich, 4th edition, 1986; van Valkenburg, "Pesticides Formulations", Marcel Dekker NY, 1973; K. Martens, "Spray Drying Handbook", 3rd Ed.1979,G. Goodwin Ltd. London. The necessary formulation aids such as inert materials, surfactants, solvents, and other additives are also known and are described, for example, in: Watkins, "Handbook of Insecticide Dust Diluents and Carriers," 2nd Ed., Darland Books, Caldwell NJ; Hv Olphen, "Introduction to Clay Colloid Chemistry"; 2nd Ed., J. Wiley & Sons, NY; Marsden, "Solvents Guide," 2nd Ed., Interscience, NY 1963; McCutcheon's, "Detergents and Emulsifiers Annual," MC Publ. Corp., Ridegewood NJ; Sisley and Wood, "Encyclopedia of Surface Active Ingredients," Chem. Publ. Co. Inc., NY 1964; Schönfeldt, "Grenzflächenaktive Äthylenoxidaddukte," Wiss. Verlagsgesellschaft, Stuttgart 1976, Winnacker-Küchler, "Chemical Technology", Volume 7, C. Hanser Verlag Munich, 4th edition 1986. On the basis of these formulations, combinations with other pesticidally active substances, such as other herbicides, fungicides,Insecticides or other pesticides (e.g. acaricides, nematicides, molluscicides, rodenticides, aphicides, avicides, larvicides, ovicides, bactericides, virucides, etc.), as well as other safeners, fertilizers and / or growth regulators, e.g. in the form of a ready-to-use formulation or as a tank mix. Wettable powders are preparations that are evenly dispersible in water and contain, in addition to the active ingredient and a diluent or inert substance, ionic and / or non-ionic surfactants (wetting agents, dispersants), e.g., polyethoxylated alkylphenols, polyethoxylated fatty alcohols, polyethoxylated fatty amines, fatty alcohol polyglycol ether sulfates, alkanesulfonates, alkylbenzenesulfonates, sodium ligninsulfonate, sodium 2,2'-dinaphthylmethane-6,6'-disulfonate, sodium dibutylnaphthalenesulfonate, or sodium oleoylmethyltaurine. For the manufacture of the wettable powders, the herbicidal active ingredients are, for example, milled in conventional equipment such as hammer mills,The active ingredient is finely ground in fan mills and air jet mills and mixed simultaneously or subsequently with the formulation auxiliaries. Emulsifiable concentrates are produced by dissolving the active ingredient in an organic solvent, e.g., butanol, cyclohexanone, dimethylformamide, xylene, or higher-boiling aromatics or hydrocarbons, or mixtures of organic solvents, with the addition of one or more ionic and / or non-ionic surfactants (emulsifiers). Examples of emulsifiers that can be used are calcium salts of alkylarylsulfonic acid, such as calcium dodecylbenzenesulfonate, or non-ionic emulsifiers, such as fatty acid polyglycol esters, alkylaryl polyglycol ethers, fatty alcohol polyglycol ethers, propylene oxide-ethylene oxide condensation products, alkyl polyethers, and sorbitan esters, such as sorbitan fatty acid esters or polyoxyethylene sorbitan fatty acid esters. Dusts are obtained by grinding the active ingredient with finely divided solid substances, e.g. talc,natural clays, such as kaolin, bentonite, and pyrophyllite, or diatomaceous earth. Suspension concentrates can be water- or oil-based. They can be produced, for example, by wet grinding using commercially available bead mills and, if necessary, with the addition of surfactants, as already listed above for the other formulation types. Emulsions, e.g., oil-in-water emulsions (EW), can be produced, for example, using stirrers, colloid mills, and / or static mixers using aqueous organic solvents and, if necessary, surfactants, as already listed above for the other formulation types. Granules can be produced either by spraying the active ingredient onto adsorptive, granulated inert material or by applying active ingredient concentrates to the surface of carrier materials such as sand using adhesives, e.g., polyvinyl alcohol, sodium polyacrylate, or mineral oils.Kaolinite or granulated inert material. Suitable active ingredients can also be granulated in the manner customary for the production of fertilizer granules – if desired, in a mixture with fertilizers. Water-dispersible granules are generally produced by processes such as spray drying, fluidized-bed granulation, disc granulation, mixing with high-speed mixers, and extrusion without solid inert material. The agrochemical preparations generally contain 0.1 to 99% by weight, in particular 0.2 to 95% by weight, of active ingredients of components (A) and / or (B). Depending on the type of formulation, the following concentrations are usual: In wettable powders, the active ingredient concentration is, for example, about 10 to 95% by weight, the remainder to 100% by weight consisting of customary formulation components. In emulsifiable concentrates, the active ingredient concentration can be about 1 to 90% by weight.preferably 5 to 80% by weight. Dust-like formulations usually contain 5 to 20% by weight of active ingredient, sprayable solutions contain approximately 0.05 to 80, preferably 2 to 50% by weight (wt. %) of active ingredient. In granules such as dispersible granules, the active ingredient content depends partly on whether the active compound is liquid or solid and which granulation aids and fillers are used. As a rule, the content for water-dispersible granules is between 1 and 95% by weight, preferably between 10 and 80% by weight. In addition, the above-mentioned active ingredient formulations may contain the usual adhesives, wetting agents, dispersants, emulsifiers, penetration agents, preservatives, antifreeze agents, solvents, fillers, dyes, carriers, defoamers, evaporation inhibitors, and agents.which influence the pH or viscosity. For application, the formulations available in commercial form are diluted, if necessary, in the usual way, e.g., with water in the case of wettable powders, emulsifiable concentrates, dispersions, and water-dispersible granules. Dust-like preparations, soil or broadcast granules, and sprayable solutions are not usually diluted with other inert substances before application. The herbicide / safener combinations according to the invention can be applied to the plants, plant parts, plant seeds, or the cultivated area (arable soil), preferably to the green plants and plant parts and, if appropriate, additionally to the arable soil. One possible application is the joint application of the herbicide / safener combinations in the form of tank mixtures.wherein the optimally formulated concentrated formulations of the individual active ingredients are mixed together with water in a tank, and the resulting spray mixture is applied. A joint formulation of the herbicide / safener combinations according to the invention has the advantage of being easier to use because the amounts of the components are already adjusted in the correct ratio to one another. Furthermore, the auxiliaries in the formulation can be optimally matched to one another, whereas a tank mix of different formulations can result in undesirable combinations of auxiliaries. General formulation examples a)-f): a) A dust is obtained by mixing 10 parts by weight (= parts by weight) of a component (A) or (B) or a component mixture (A) + (B) (and optionally further components) and / or their salts and 90 parts by weight of talc as an inert substance and comminuting in a hammer mill. b) A readily water-dispersible,A wettable powder is obtained by mixing 25 parts by weight of a component or a component mixture, 64 parts by weight of kaolin-containing quartz as an inert material, 10 parts by weight of potassium ligninsulfonate, and 1 part by weight of sodium oleoylmethyltaurine as a wetting and dispersing agent, and grinding the mixture in a pin-type mill. c) A dispersion concentrate that is easily dispersible in water is obtained by mixing 20 parts by weight of a component or a component mixture with 6 parts by weight of alkylphenol polyglycol ether (®Triton X 207), 3 parts by weight of isotridecanol polyglycol ether (8 EO), and 71 parts by weight of paraffinic mineral oil (boiling range, for example, approx. 255 to 277 °C) and grinding the mixture in a ball mill to a fineness of less than 5 microns. d) An emulsifiable concentrate is obtained from 15 parts by weight of a component or a mixture of components,75 parts by weight of cyclohexanone as solvent and 10 parts by weight of ethoxylated nonylphenol as emulsifier. e) Water-dispersible granules are obtained by mixing 75 parts by weight of one component of a component mixture, 10 parts by weight of calcium ligninsulfonate, 5 parts by weight of sodium lauryl sulfate, 3 parts by weight of polyvinyl alcohol, and 7 parts by weight of kaolin, grinding the mixture in a pin mill, and granulating the powder in a fluidized bed by spraying water as the granulating liquid. f) A water-dispersible granulate is also obtained by homogenising and pre-crushing 25 parts by weight of one component of a component mixture, 5 parts by weight of 2,2'-dinaphthylmethane-6,6'-disulfonic acid sodium, 2 parts by weight of oleoylmethyltauric acid sodium, 1 part by weight of polyvinyl alcohol, 17 parts by weight of calcium carbonate and 50 parts by weight of water on a colloid mill,subsequently ground in a bead mill, and the resulting suspension is atomized and dried in a spray tower using a single-component nozzle. BIOLOGICAL EXAMPLES Effect of selected herbicide / safener combinations according to the invention, using the example of pest reduction on spring wheat (TRZAS) and barley (HORVS): The seeds of the crops to be treated were placed in soil in plastic pots (diameter ~7 cm), covered with soil, and grown in a greenhouse under favorable conditions for germination and growth. The test plants were treated in the early leaf stage (BBCH11-12). The safeners were first applied to the above-ground parts of the plants, and immediately after the sprayed plant parts had dried, the herbicide treatment was carried out. All safeners used were applied as wettable powders (WP) at a dose of 100 g / ha with a water application rate corresponding to 300 l / ha, with the addition of the formulation aid (0.5%).2% Genapol-X080) was sprayed onto the above-ground parts of the plants. The herbicides used were formulated as wettable powders (WP), emulsifiable concentrates (EC), and / or water-soluble concentrates (SL), mixed according to the respective specified dosage, and sprayed onto the above-ground parts of the plants at a water application rate corresponding to 300 l / ha with the addition of formulation aids (Mero, 1.5 l / ha and diammonium phosphate, 1 g / ha). The dosage of the respective herbicides was selected so that, at the time of evaluation, they caused moderate, visually clearly detectable damage (min. 15%,max. 70%) compared to untreated crops. After application, the plants were cultivated in a greenhouse under favorable growth conditions. 21 days after application, a visual assessment of the herbicide damage was carried out. The damage was visually assessed on a scale of 0-100% in comparison to untreated control plants and averaged over two replicates per treatment. Examples: 0% = no discernible effect compared to the untreated plant 20% = the treated plant population is 20% damaged compared to the untreated control population (e.g., growth height, leaf damage, etc.) 100% = treated plants completely damaged or dead. The experiments show,that damage to the crops spring wheat (TRZAS; cv. Triso) and barley (HORVS; cv. Accordine) (= herbicide damage without safener in Tables 5 and 6 below) caused by the respective herbicide (component (B)) is significantly reduced by the addition of a safener (component (A)). The safeners were each applied at a rate of 100 g / ha.

Claims

1. Herbicide / safener combination comprising one or more compounds (A) acting as safeners and one or more herbicidally active compounds (B), where (A) is one or more compounds of the general formula (I) or their agrochemically acceptable salts, and where (R a ) p -Phenyl for groups Q-1.1 to Q-1.55 stands, and (R b ) q -Phenyl for groups Q-2.1 to Q-2.55 stands, R c stands for hydrogen, and R dfür Wasserstoff, Methyl, Ethyl, n-Propyl, i-Propyl, n-Butyl, n-Pentyl, Phenyl, Benzyl, CH2(4-Cl-Ph), CH2(4-F-Ph), CH2(4-OMe-Ph), 2-Methoxyethyl, Tetrahydrofuran-2-yl- methyl, Tetrahydrofuran-3-yl-methyl, Tetrahydropyran-2-yl-methyl, Tetrahydropyran-3-yl- methyl, Tetrahydropyran-4-yl-methyl, Methylpropionat-3-yl, Ethylpropionat-3-yl, Methylacetat-2-yl, Ethylacetat-2-yl, Methylpivalat-2-yl, Ethylpivalat-3-yl, Methyl-2- methylpropanoat-3-yl, Methyl-2,2-dimethylpropanoat-3-yl, Ethyl-2-methylpropanoat-3-yl, Methyl-2-propanoat-2-yl, Ethyl-2-propanoat-2-yl, Methyl-acetat-2yl, Ethyl-acetat-2yl, Methyl-1-methylcyclopropancarboxylat-2yl, Ethyl-1-methylcyclopropan-carboxylat-2yl, 2-(Dimethylamino)ethyl, Oxetan-3-yl, (3-Methyloxetan-3-yl)methyl, 2,2,2-Trifluorethyl, 2,2-Difluoroethyl, 2-Fluoroethyl, 2,2,3,3,3-Pentafluoropropyl, Cyclopropylmethyl, 1-Cyclopropyl-ethyl, (1-Methyl-cyclopropyl)-methyl, (2,2-Dichlorocyclopropyl)-methyl, (2,2-Dimethyl-cyclopropyl)-methyl, Allyl, Propargyl (Prop-2-yn-1-yl), 2-Chloroprop-2-en-1-yl, 3-Phenylprop-2-yn-1-yl, 3,3-Dichloroprop-2-en-1-yl, 3,3-Dichloro-2-fluoro-prop-2-en-1-yl, Methylprop-2-yn-1-yl, 2-Methylprop-2-en-1-yl, But-2-en-1-yl, But-3-en-1-yl, But-2-yn-1-yl, but-3-yn-1-yl, 4-chloro-but-2-yn-1-yl, 3-methyl-but-2-en-1-yl, 3-methyl-but-1-en-1-yl, 1-(2E)-1-methylbut-2-en-1-yl, (E)-pent-3-en-2-yl or (Z)-pent-3-en-2-yl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl, heptan-2-yl, iso-butyl, 1,3-dioxolan-2-ylmethyl or 1-ethyl-5-methyl-1-pyrazol-4-methyl, and (B) represents one or more compounds of the general formula (II) or their agrochemically acceptable salts, where R 1represents (C1-C3)-alkoxy, (C1-C2)-alkoxy-(C1-C3)-alkoxy, (C1-C2)-fluoroalkoxy, ethyl, n-propyl, n-butyl, cyclopropyl or ethynyl, R 2 represents hydrogen, ethyl, n-propyl, cyclopropyl, vinyl, ethynyl, (C1-C3)-alkoxy, (C1-C3)-fluoroalkyl, (C1-C2)-fluoroalkoxy, (C1-C2)-alkoxy-(C1-C3)-alkoxy- or C1-fluoroalkoxy-(C1-C3)-alkoxy-; provided that R 2 represents hydrogen, ethyl, n-propyl, cyclopropyl, vinyl or ethynyl, if R 1 represents ethyl, n-propyl, n-butyl, cyclopropyl or ethynyl, R 3 , R 4 , R 5 and R 6independently of one another represent hydrogen, (C1-C5)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, (C1-C2)-fluoroalkyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, (C1-C3)-alkylthio-(C1-C3)-alkyl, (C1-C3)-alkylsulfinyl-(C1-C3)-alkyl, (C1-C3)-alkylsulfonyl-(C1-C3)-alkyl, (C3-C4)-cycloalkyl or represent an unsubstituted 4, 5 or 6-membered monocyclic heterocyclyl ring which carries a ring heteroatom selected from the group consisting of oxygen, sulfur or nitrogen and which is attached to a ring carbon atom within the heterocyclyl group, preferably tetrahydrofuranyl such as tetrahydrofuran-3-yl, or tetrahydropyranyl such as tetrahydropyran-4-yl, with the proviso that not more than one of the radicals from the group R 3 , R 4 , R 5 and R 6 represents alkenyl, alkynyl, alkoxyalkyl, alkylthioalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl, cycloalkyl or heterocyclyl, or R 3 and R 4together a group -(CH2) n1 - or -(CH2) n2 -X 1 -(CH2) n3 - form and R 5 and R 6 as defined above, or R 5 and R 6 together a group -(CH2) n1 - or -(CH2) n2 -X 1 -(CH2) n3 - form and R 3 and R 4 as defined above, where X 1 represents O (oxygen), S (sulfur), S(=O), S(=O)2, NH, N((C1-C2)-alkyl), N((C1-C2)-alkoxy), C(H)((C1-C2)-alkyl), C((C1-C2)-alkyl)2 or C(H)((C1-C2)-alkoxy); n1 represents 2, 3, 4 or 5, n2 and n3 independently represent 1, 2 or 3, provided that n2 + n3 is equal to 2, 3 or 4, or R 4 and R 5 together a group -(CH2) n4 - or -(CH2) n5 -C(R 7a )(R 7b )-(CH2) n6 - or -C(R 7c )=C(R 7d )-, where R 7a represents (C1-C2)-alkyl or (C1-C2)-alkoxy; and R 7brepresents hydrogen or (C1-C2)-alkyl, provided that R 7b represents hydrogen when R 7a represents (C1-C2)-alkoxy and wherein n4 represents 1, 2 or 3 and n5 and n6 independently represent 0, 1 or 2, with the proviso that n5 + n6 is equal to 0, 1 or 2 and wherein R 7c and R 7d independently of one another represent hydrogen or (C1-C2)-alkyl, Y represents O (oxygen), S (sulfur), S(=O), S(=O)2, N((C1-C2)-alkyl), N((C1-C2)-alkoxy), C(=O), a group CR 8 R 9 or -CR 10 R 11 CR 12 R 13 - stands, R 8 and R 9independently of one another represent hydrogen, (C1-C6)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, (C1-C2)-fluoroalkyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, (C1-C3)-alkylthio-(C1-C3)-alkyl, (C1-C3)-alkylsulfinyl-(C1-C3)-alkyl, (C1-C3)-alkylsulfonyl-(C1-C3)-alkyl, (C3-C6)-cycloalkyl or substituted (C3-C6)-cycloalkyl which is independently substituted by one or two (C1-C3)-alkyl or (C1-C2)-fluoroalkyl groups or (C4-C6)-cycloalkyl in which one CH2 group is optionally substituted by O (oxygen), S (sulfur), S(=O), S(=O)2, NH, N((C1-C3)-alkyl), N((C1-C2)-alkoxy), N((C1-C2)-fluoroalkyl), N[C(=O)-(C1-C3)-alkyl], N[C(=O)-(C1-C2)-fluoroalkyl] or represents (C3-C6)-cycloalkyl which is substituted by a (C1-C3)-alkoxy group and optionally additionally substituted by a (C1-C2)-alkyl group or represents (C5-C6)-cycloalkenyl or (C5-C6)-cycloalkenyl,which bears one or two (C1-C3)-alkyl substituents or for (C3-C6)-cycloalkyl-(C1-C2)-alkyl or for substituted (C3-C6)-cycloalkyl-(C1-C2)-alkyl which is independently substituted by one or two (C1-C3)-alkyl or (C1-C2)-fluoroalkyl groups or for (C4-C6)-cycloalkyl-(C1-C2)-alkyl in which one CH2-, Group in the ring is optionally substituted by O (oxygen), S (sulfur), S(=O), S(=O)2, NH, N((C1-C2)-alkyl), N((C1-C2)-alkoxy), N((C1-C2)-fluoroalkyl), N[C(=O)-(C1-C3)-alkyl], N[C(=O)-(C1-C2)-fluoroalkyl] or represents (C3-C6)-cycloalkyl-(C1-C2)-alkyl, which is substituted on the ring by a (C1-C3)-alkoxy group and optionally additionally substituted on the ring by a (C1-C2)-alkyl group or represents heteroaryl, heteroaryl-CH2-, where the heteroaryl ring is attached via a ring carbon atom and is optionally further substituted by 1, 2 or 3 ring carbon atoms bonded Substituents from the group halogen, cyano, nitro, hydroxy, (C1-C3)-alkyl, (C1-C3)-alkyl-C(=O)-, (C1-C2)-fluoroalkyl-C(=O)-, (C1-C3)-alkoxy, (C1-C2)-fluoroalkoxy, (C2-C3)-alkenyl, (C2-C3)-alkynyl, (C1-C2)-fluoroalkyl with the proviso that a ring carbon atom is not replaced by a halogen (except fluorine),Alkoxy or fluoroalkoxy is substituted if this ring carbon atom is directly bonded to a ring nitrogen atom of the heteroaryl ring; and in the case of a 5-membered heteroaryl group which carries at least one nitrogen atom in the ring and which is not part of a C=N double bond, this nitrogen atom is optionally substituted by a substituent from the group (C1-C3)-alkyl, (C1-C2)-fluoroalkyl, (C1-C3)-alkyl-C(=O)-, (C1-C2)-fluoroalkyl-C(=O)-, (C1-C2)-alkyl-S(=O)2-, with the proviso that a maximum of one of the two substituents R, 8 and R 9an optionally substituted cycloalkyl; an optionally substituted cycloalkyl in which one ring (CH2) unit is replaced by O (oxygen), S (sulfur), S(=O), S(=O)2, NH, N((C1-C3)-alkyl), N((C1-C2)-fluoroalkyl), N[C(=O)-(C1-C3)-alkyl], N[C(=O)-(C1-C2)-fluoroalkyl] or N((C1-C2)-alkoxy); an optionally substituted cycloalkenyl; an optionally substituted cycloalkylalkyl; an optionally substituted cycloalkylalkyl in which one ring (CH2) unit is replaced by O (oxygen), S (sulfur), S(=O), S(=O)2, NH, N((C1-C3)-alkyl), N((C1-C2)-fluoroalkyl), N[C(=O)-(C1-C3)-alkyl], N[C(=O)-(C1-C2)-fluoroalkyl] or N((C1-C2)-alkoxy); or heteroaryl or heteroaryl-CH2-; or R 8 represents hydrogen or (C1-C2)-alkyl when R 9 represents (C1-C2)-alkoxy, R 8 and R 9 together for -(CH2)n7- or -(CH2)n8-X 2 -(CH2)n9-, where X 2represents O (oxygen), S (sulfur), S(=O), S(=O)2, C(H)[(C1-C3)-alkyl], C[(C1-C2)-alkyl]2, C(H)[(C1-C3)-alkoxy] and n7 represents 2, 3, 4, 5, and 6 and n8 and n9 independently represent 0, 1, 2, 3, with the proviso that n8 + n9 is equal to 2, 3, 4, 5, R 10 , R 11 , R 12 and R 13 independently represent hydrogen, (C1-C4)-alkyl, provided that no more than one group R 10 , R 11 , R 12 and R 13 represents (C3-C4)alkyl, G stands for hydrogen, an agronomically acceptable metal, an agronomically acceptable sulfonium group, an agronomically acceptable ammonium group, a group C(X 3 )-R 14 , -C(X 4 )-X 5 -R 15 , -C(X 6 )- N(R 16 )-R 17 , -SO2-R 18 , -P(X 7 )(R 19 )-R 20 , -CH2-X 8 -R 21, (C1-C6)-alkoxy-C(=O)-CH2-, (C1-C6)-alkoxy-C(=O)-CH=CH-, (C2-C7)-alken-1-yl-CH2-, (C2-C7)-alken-1-yl-CH[(C1-C2)-alkyl]-, (C2- C4)-fluoroalken-1-yl-CH2-, (C2-C7)-alkyn-1-yl-CH2-, (C2-C7)-alkyn-1-yl-CH[(C1-C2)-alkyl]-, heteroaryl-CH2-, heteroaryl-CH[(C1-C2)-alkyl]-, phenyl-CH2-, Phenyl-CH[(C1-C2)-alkyl]-, phenyl-C(O)-CH2- is where the phenyl or heteroaryl group optionally continues is independently substituted by 1, 2 or 3 groups selected from (C1-C2)-alkyl, C1-fluoroalkyl, (C1-C2)-alkoxy, C1-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, X 3 , X 4 , X 5 , X 6 , X 7 and X 8 independently represent O (oxygen) and S (sulfur), R 14 represents hydrogen, (C1-C21)-alkyl, (C2-C21)-alkenyl, (C2-C 18 )-alkynyl, (C1-C 10 )-fluoroalkyl, (C1- C 10 )-cyanoalkyl, (C1-C 10 )-nitroalkyl, (C1-C 10)-Aminoalkyl, (C1-C5)-Alkylamino(C1-C5)-alkyl, (C2-C8)-Dialkylamino(C1-C5)-alkyl, (C3-C7)-Cycloalkyl-(C1-C5)-alkyl, (C1-C5)-Alkoxy-(C1-C5)- alkyl, (C3-C5)-Alkenyloxy-(C1-C5)-alkyl, (C3-C5)-Alkinyloxy-(C1-C5)-alkyl, (C1-C5)-Alkylthio- (C1-C5)-alkyl, (C1-C5)-Alkylsulfinyl-(C1-C5)-alkyl, (C1-C5)-Alkylsulfonyl-(C1-C5)-alkyl, (C2-C8)- Alkylidenaminoxy(C1-C5)-alkyl, (C1-C5)-Alkylcarbonyl-(C1-C5)-alkyl, (C1-C5)- Alkoxycarbonyl(C1-C5)-alkyl, Aminocarbonyl-(C1-C5)-alkyl, (C1-C5)-Alkylaminocarbonyl-(C1- C5)-alkyl, (C2-C8)-Dialkylaminocarbonyl-(C1-C5)-alkyl, (C1-C5)-Alkylcarbonylamino-(C1-C5)- alkyl, N-(C1-C5)-Alkylcarbonyl-N-(C1-C5)-alkylamino(C1-C5)-alkyl, (C3-C6)-Trialkylsilyl-(C1- C5)-alkyl, Phenyl-(C1-C5)-alkyl, wobei die Phenylgruppe gegebenenfalls weiter unabhänig voneinander durch 1, 2 oder 3 Gruppen ausgewählt aus (C1-C3)-Alkyl, (C1-C3)-FluoralkyI, (C1- C2)-Alkoxy, (C1-C3)-Fluoralkoxy, (C1-C3)-Alkylthio, (C1-C3)-Alkylsulfinyl, (C1-C3)- Alkylsulfonyl, Fluor, Chlor, Brom, Cyano,Nitro is substituted, heteroaryl-(C1-C5)-alkyl, wherein the heteroaryl group is optionally further substituted independently of one another by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, fluorine, chlorine, bromine, cyano, nitro, (C2-C5)-fluoroalkenyl, (C3-C8)-cycloalkyl; Phenyl or phenyl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroaryl or which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, R, 15 for (C1-C 18 )-alkyl, (C3-C 18 )-alkenyl, (C3-C 18 )-alkynyl, (C2-C 10 )-fluoroalkyl, (C1-C 10 )-cyanoalkyl, (C1-C10 )-Nitroalkyl, (C2-C 10 )-Aminoalkyl, (C1-C5)-Alkylamino(C1-C5)-alkyl, (C2-C8)- Dialkylamino(C1-C5)-alkyl, (C3-C7)-Cycloalkyl-(C1-C5)-alkyl, (C1-C5)-Alkoxy-(C1-C5)-alkyl, (C3- C5)-Alkenyloxy-(C1-C5)-alkyl, (C3-C5)-Alkinyloxy-(C1-C5)-alkyl, (C1-C5)-Alkylthio-(C1-C5)- alkyl, (C1-C5)-Alkylsulfinyl-(C1-C5)-alkyl, (C1-C5)-Alkylsulfonyl-(C1-C5)-alkyl, (C2-C8)- Alkylidenaminoxy(C1-C5)-alkyl, (C1-C5)-Alkylcarbonyl-(C1-C5)-alkyl, (C1-C5)- Alkoxycarbonyl(C1-C5)-alkyl, Aminocarbonyl-(C1-C5)-alkyl, (C1-C5)-Alkylaminocarbonyl-(C1- C5)-alkyl, (C2-C8)-Dialkylaminocarbonyl-(C1-C5)-alkyl, (C1-C5)-Alkylcarbonylamino-(C1-C5)- alkyl, N-(C1-C5)-Alkylcarbonyl-N-(C1-C5)-alkylamino(C1-C5)-alkyl, (C3-C6)-Trialkylsilyl-(C1- C5)-alkyl, Phenyl-(C1-C5)-alkyl, wobei die Phenylgruppe gegebenenfalls weiter unabhänig voneinander durch 1, 2 oder 3 Gruppen ausgewählt aus (C1-C3)-Alkyl, (C1-C3)-FluoralkyI, (C1- C2)-Alkoxy, (C1-C3)-Fluoralkoxy, (C1-C3)-Alkylthio, (C1-C3)-Alkylsulfinyl, (C1-C3)- Alkylsulfonyl, Fluor, Chlor, Brom, Cyano, Nitro substituiert ist, Heteroaryl-(C1-C5)-alkyl,wherein the heteroaryl group is optionally further substituted independently by 1, 2 or 3 groups selected from (C1-C3)alkyl, (C1-C3)fluoroalkyl, (C1-C2)alkoxy, (C1-C3)fluoroalkoxy, (C1-C3)alkylthio, (C1-C3)alkylsulfinyl, (C1-C3)alkylsulfonyl, fluorine, chlorine, bromine, cyano, nitro, (C2-C5)fluoroalkenyl, (C3-C8)cycloalkyl; Phenyl or phenyl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroaryl or heteroaryl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, R, 16 and R 17 independently of each other for hydrogen, (C1-C 10 )-alkyl, (C2-C 10 )-alkenyl, (C2-C 10 )- alkynyl, (C2-C 10 )-fluoroalkyl, (C1-C 10)-Cyanoalkyl, (C1-C 10 )-Nitroalkyl, (C1-C 10)-Aminoalkyl, (C1- C5)-Alkylamino(C1-C5)-alkyl, (C2-C8)-Dialkylamino(C1-C5)-alkyl, (C3-C7)-Cycloalkyl-(C1-C5)- alkyl, (C1-C5)-Alkoxy-(C1-C5)-alkyl, (C3-C5)-Alkenyloxy-(C1-C5)-alkyl, (C3-C5)-Alkinyloxy-(C1- C5)-alkyl, (C1-C5)-Alkylthio-(C1-C5)-alkyl, (C1-C5)-Alkylsulfinyl-(C1-C5)-alkyl, (C1-C5)- Alkylsulfonyl-(C1-C5)-alkyl, (C2-C8)-Alkylidenaminoxy(C1-C5)-alkyl, (C1-C5)-Alkylcarbonyl-(C1- C5)-alkyl, (C1-C5)-Alkoxycarbonyl(C1-C5)-alkyl, Aminocarbonyl-(C1-C5)-alkyl, (C1-C5)- Alkylaminocarbonyl-(C1-C5)-alkyl, (C2-C8)-Dialkylaminocarbonyl-(C1-C5)-alkyl, (C1-C5)- Alkylcarbonylamino-(C1-C5)-alkyl, N-(C1-C5)-Alkylcarbonyl-N-(C1-C5)-alkylamino(C1-C5)-alkyl, (C3-C6)-Trialkylsilyl-(C1-C5)-alkyl, Phenyl-(C1-C5)-alkyl, wobei die Phenylgruppe gegebenenfalls weiter unabhänig voneinander durch 1, 2 oder 3 Gruppen ausgewählt aus (C1-C3)-Alkyl, (C1-C3)- FluoralkyI, (C1-C2)-Alkoxy, (C1-C3)-Fluoralkoxy, (C1-C3)-Alkylthio, (C1-C3)-Alkylsulfinyl, (C1- C3)-Alkylsulfonyl, Fluor, Chlor, Brom, Cyano,Nitro is substituted, heteroaryl-(C1-C5)-alkyl, wherein the heteroaryl group is optionally further substituted independently by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, fluorine, chlorine, bromine, cyano, nitro is substituted, (C2-C5)-fluoroalkenyl, (C3-C8)-cycloalkyl; Phenyl or phenyl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroaryl or heteroaryl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroarylamino or heteroarylamino in which the heteroaryl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, diheteroarylamino or diheteroarylamino, in which the respective heteroaryl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano,Nitro is substituted, Phenylamino or Phenylamino, in which the respective phenyl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, Diphenylamino or Diphenylamino, in which the respective phenyl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, (C3-C7)-cycloalkylamino, Di-[(C3-C7)-cycloalkyl]amino, (C3-C7)-cycloalkoxy, or R, 16 and R 17 , together with the nitrogen atom to which they are attached, form an unsubstituted 4- to 7-membered ring, optionally comprising a heteroatom selected from the group consisting of O (oxygen) and S (sulfur), R 18 for (C1-C 10 )-alkyl, (C2-C 10 )-alkenyl, (C2-C 10 )-alkynyl, (C1-C 10 )-fluoroalkyl, (C1-C10 )-Cyanoalkyl, (C1-C 10 )-Nitroalkyl, (C1-C 10)-Aminoalkyl, (C1-C5)-Alkylamino(C1-C5)-alkyl, (C2-C8)- Dialkylamino(C1-C5)-alkyl, (C3-C7)-Cycloalkyl-(C1-C5)-alkyl, (C1-C5)-Alkoxy-(C1-C5)-alkyl, (C3- C5)-Alkenyloxy-(C1-C5)-alkyl, (C3-C5)-Alkinyloxy-(C1-C5)-alkyl, (C1-C5)-Alkylthio-(C1-C5)- alkyl, (C1-C5)-Alkylsulfinyl-(C1-C5)-alkyl, (C1-C5)-Alkylsulfonyl-(C1-C5)-alkyl, (C2-C8)- Alkylidenaminoxy(C1-C5)-alkyl, (C1-C5)-Alkylcarbonyl-(C1-C5)-alkyl, (C1-C5)- Alkoxycarbonyl(C1-C5)-alkyl, Aminocarbonyl-(C1-C5)-alkyl, (C1-C5)-Alkylaminocarbonyl-(C1- C5)-alkyl, (C2-C8)-Dialkylaminocarbonyl-(C1-C5)-alkyl, (C1-C5)-Alkylcarbonylamino-(C1-C5)- alkyl, N-(C1-C5)-Alkylcarbonyl-N-(C1-C5)-alkylamino(C1-C5)-alkyl, (C3-C6)-Trialkylsilyl-(C1- C5)-alkyl, Phenyl-(C1-C5)-alkyl, wobei die Phenylgruppe gegebenenfalls weiter unabhänig voneinander durch 1, 2 oder 3 Gruppen ausgewählt aus (C1-C3)-Alkyl, (C1-C3)-FluoralkyI, (C1- C2)-Alkoxy, (C1-C3)-Fluoralkoxy, (C1-C3)-Alkylthio, (C1-C3)-Alkylsulfinyl, (C1-C3)- Alkylsulfonyl, Fluor, Chlor, Brom, Cyano,Nitro is substituted, heteroaryl-(C1-C5)-alkyl, wherein the heteroaryl group may optionally be further substituted independently by 1, 2 or 3 groups, selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyI, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, fluorine, chlorine, bromine, cyano, nitro substituted is, (C2-C5)-fluoroalkenyl, (C3-C8)-cycloalkyl; Phenyl or phenyl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroaryl or heteroaryl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroarylamino or heteroarylamino in which the heteroaryl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, diheteroarylamino or diheteroarylamino,in which the respective heteroaryl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, phenylamino or phenylamino, in which the respective phenyl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, diphenylamino or diphenylamino, in which the respective phenyl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro is substituted, (C3-C7)-cycloalkylamino, di-[(C3-C7)-cycloalkyl]amino, (C3-C7)-cycloalkoxy, (C1-C, 10 )-alkoxy, (C1-C 10 )-fluoroalkoxy, (C3-C7)-alkylamino, di-[(C3-C7)-alkyl]amino, R 19 and R 20 independently for (C1-C 10)-Alkyl, (C2-C 10 )-Alkenyl, (C2-C 10 )-Alkinyl, (C1-C 10 )- Fluoralkyl, (C1-C 10 )-Cyanoalkyl, (C1-C 10 )-Nitroalkyl, (C1-C 10)-Aminoalkyl, (C1-C5)- Alkylamino(C1-C5)-alkyl, (C2-C8)-Dialkylamino(C1-C5)-alkyl, (C3-C7)-Cycloalkyl-(C1-C5)-alkyl, (C1-C5)-Alkoxy-(C1-C5)-alkyl, (C3-C5)-Alkenyloxy-(C1-C5)-alkyl, (C3-C5)-Alkinyloxy-(C1-C5)- alkyl, (C1-C5)-Alkylthio-(C1-C5)-alkyl, (C1-C5)-Alkylsulfinyl-(C1-C5)-alkyl, (C1-C5)- Alkylsulfonyl-(C1-C5)-alkyl, (C2-C8)-Alkylidenaminoxy(C1-C5)-alkyl, (C1-C5)-Alkylcarbonyl-(C1- C5)-alkyl, (C1-C5)-Alkoxycarbonyl(C1-C5)-alkyl, Aminocarbonyl-(C1-C5)-alkyl, (C1-C5)- Alkylaminocarbonyl-(C1-C5)-alkyl, (C2-C8)-Dialkylaminocarbonyl-(C1-C5)-alkyl, (C1-C5)- Alkylcarbonylamino-(C1-C5)-alkyl, N-(C1-C5)-Alkylcarbonyl-N-(C1-C5)-alkylamino(C1-C5)-alkyl, (C3-C6)-Trialkylsilyl-(C1-C5)-alkyl, Phenyl-(C1-C5)-alkyl, wobei die Phenylgruppe gegebenenfalls weiter unabhänig voneinander durch 1, 2 oder 3 Gruppen ausgewählt aus (C1-C3)-Alkyl, (C1-C3)- FluoralkyI, (C1-C2)-Alkoxy, (C1-C3)-Fluoralkoxy, (C1-C3)-Alkylthio, (C1-C3)-Alkylsulfinyl, (C1- C3)-Alkylsulfonyl, Fluor, Chlor, Brom, Cyano,Nitro is substituted, heteroaryl-(C1-C5)-alkyl, wherein the heteroaryl group may optionally be further substituted independently by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, fluorine, chlorine, bromine, cyano, nitro, (C2-C5)-fluoroalkenyl, (C3-C8)-cycloalkyl; Phenyl or phenyl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroaryl or heteroaryl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroarylamino or heteroarylamino in which the heteroaryl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, diheteroarylamino or diheteroarylamino, in which the respective heteroaryl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl,(C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, phenylamino or phenylamino, in which the respective phenyl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, diphenylamino or diphenylamino, in which the respective phenyl group is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro is substituted, benzyloxy and phenyloxy, wherein the respective phenyl group is optionally further substituted independently of one another by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, and R, 21 for (C1-C 10 )-alkyl, (C3-C 10 )-alkenyl, (C3-C 10 )-alkynyl, (C1-C10 )-Fluoralkyl, (C1-C 10 )-Cyanoalkyl, (C1-C 10 )-Nitroalkyl, (C2-C 10)-Aminoalkyl, (C1-C5)-Alkylamino(C1-C5)-alkyl, (C2-C8)- Dialkylamino(C1-C5)-alkyl, (C3-C7)-Cycloalkyl-(C1-C5)-alkyl, (C1-C5)-Alkoxy-(C1-C5)-alkyl, (C3- C5)-Alkenyloxy-(C1-C5)-alkyl, (C3-C5)-Alkinyloxy-(C1-C5)-alkyl, (C1-C5)-Alkylthio-(C1-C5)- alkyl, (C1-C5)-Alkylsulfinyl-(C1-C5)-alkyl, (C1-C5)-Alkylsulfonyl-(C1-C5)-alkyl, (C2-C8)- Alkylidenaminoxy(C1-C5)-alkyl, (C1-C5)-Alkylcarbonyl-(C1-C5)-alkyl, (C1-C5)- Alkoxycarbonyl(C1-C5)-alkyl, Aminocarbonyl-(C1-C5)-alkyl, (C1-C5)-Alkylaminocarbonyl-(C1- C5)-alkyl, (C2-C8)-Dialkylaminocarbonyl-(C1-C5)-alkyl, (C1-C5)-Alkylcarbonylamino-(C1-C5)- alkyl, N-(C1-C5)-Alkylcarbonyl-N-(C1-C5)-alkylamino(C1-C5)-alkyl, (C3-C6)-Trialkylsilyl-(C1- C5)-alkyl, Phenyl-(C1-C5)-alkyl, wobei die Phenylgruppe gegebenenfalls weiter unabhänig voneinander durch 1, 2 oder 3 Gruppen ausgewählt aus (C1-C3)-Alkyl, (C1-C3)-FluoralkyI, (C1- C2)-Alkoxy, (C1-C3)-Fluoralkoxy, (C1-C3)-Alkylthio, (C1-C3)-Alkylsulfinyl, (C1-C3)- Alkylsulfonyl, Fluor, Chlor, Brom, Cyano,Nitro is substituted, heteroaryl-(C1-C5)-alkyl, wherein the heteroaryl group may optionally be further substituted independently by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, (C1-C3)-, Alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, fluorine, chlorine, bromine, cyano, nitro, phenoxy-(C1-C5)-alkyl, where the phenyl group is optionally further substituted independently of one another by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, fluorine, chlorine, bromine, cyano, nitro, heteroaryloxy-(C1-C5)-alkyl, where the heteroaryl group is optionally further substituted independently of one another by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, fluorine, chlorine, bromine, cyano, nitro, phenyl or phenyl which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, heteroaryl or heteroaryl,which is independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro, phenyl- C(=O), wherein the phenyl group is optionally further independently substituted by 1, 2 or 3 groups selected from (C1-C3)-alkyl, (C1-C3)-fluoroalkyl, (C1-C2)-alkoxy, (C1-C3)-fluoroalkoxy, fluorine, chlorine, bromine, cyano, nitro.

2. Herbicide / safener combination according to claim 1, containing as compound (A) one or more safeners from the group consisting of compounds A1, A2, A3, A4, A5, A6, A7, A8, A9 and A10, where A1 = methyl {[1,5-bis(4-chloro-2-fluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetate, A2 = {[1,5-Bis(4-chloro-2-fluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid A3 = Methyl {[5-(4-chloro-2-fluorophenyl)-1-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetate A4 = {[5-(4-chloro-2-fluorophenyl)-1-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid A5 = Methyl {[1-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetate A6 = {[1-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid A7 = Methyl {[5-(4-bromo-2-fluorophenyl)-1-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetate A8 = {[5-(4-bromo-2-fluorophenyl)-1-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid A9 = Methoxyethyl {[1-(4-bromo-2-fluorophenyl)-5-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetate A10 = {[1-(4-bromo-2-fluorophenyl)-5-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid 3. Herbicide / safener combination according to one of claims 1 or 2, containing one or more compounds of formula (II) where R 3 and R 6 stand for hydrogen, Y stands for -CH2-, R 4 and R 5 together form a group -CH2-CH2- and form a ring with the carbon atoms to which they are attached and the group Y; and R 1 , R 2 , G and Y have the following meanings:

4. Herbicide / safener combination according to one of claims 2 to 3, comprising one or more compounds selected from A1, A3, A5, A7 and A9 and one or more compounds of the general formula (II) in which R 3 and R 6 stand for hydrogen and R 4 and R 5 together form a group -CH2-CH2- and form a ring with the carbon atoms to which they are attached and the group Y; R 1 , R 2 , G and Y have the meanings below, 5. Herbicide / safener combination according to one of claims 2 to 4, comprising one or more compounds selected from A1, A3, A5, A7 and A9 and one or more compounds selected from B1, B24 and B29, wherein B1 = 4-Hydroxy-3-[2-methoxy-4-(prop-1-yn-1-yl)phenyl]bicyclo[3.2.1]oct-3-en-2-one; B24 = sodium 3-[2-methoxy-4-(prop-1-yn-1-yl)phenyl]-4-oxobicyclo[3.2.1]oct-2-en-2-olate; B29 = 3-[2-Methoxy-4-(1-propyn-1-yl)phenyl]-4-oxobicyclo[3.2.1]oct-2-en-2-yl methyl carbonate.

6. The herbicide / safener combination according to claim 5, comprising one or more compounds selected from A3, A7, and A9 and one or more compounds selected from B1, B24, and B29, wherein B1 = 4-Hydroxy-3-[2-methoxy-4-(prop-1-yn-1-yl)phenyl]bicyclo[3.2.1]oct-3-en-2-one; B24 = sodium 3-[2-methoxy-4-(prop-1-yn-1-yl)phenyl]-4-oxobicyclo[3.2.1]oct-2-en-2-olate; B29 = 3-[2-Methoxy-4-(1-propyn-1-yl)phenyl]-4-oxobicyclo[3.2.1]oct-2-en-2-yl methyl carbonate.

7. The herbicide / safener combination according to any one of claims 1 to 6, further comprising one or more additives customary in crop protection.

8. A method for protecting crops from phytotoxic side effects of a herbicide (B), characterized in that an effective amount of a safener (A) is applied to the plants, plant parts, plant seeds, or the cultivated area before, after, or simultaneously with the herbicide (B), where the combination of herbicide (B) and safener (A) is defined according to any one of claims 1 to 7.

9. The method according to claim 8, characterized in that the crops are cereal plants.

10. The method according to claim 8 or 9, characterized in that the herbicide (B) is applied at a rate of 5 to 400 g / ha of active ingredient and in a weight ratio of safener (A) to herbicide (B) of 1:400 to 500:

1. 11.Use of the herbicide / safener combination according to any one of claims 1 to 7 for controlling weeds or regulating plant growth.

Images